ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_1295_2 # 733 # 1068 # -1 # ID=1291_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.667	k141_1295_2	733	1068	-	Strict	200	224.6	RbpA	96.4	3000245	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	RbpA bacterial RNA polymerase-binding protein	ATGGCTGATCGTGTGCTCAGGGGCAGCCGGCTCGGAGCTGTGAGCTACGAGACCGACCGCAACCACGACCTCGCGCCGCGTCAGGTCGCGCGCTACCGCACCGAGAACGGCGAGGAATTCGACGTCCCGTTCGCCGACGACGCTGAGATCCCCGGCACCTGGCTGTGCCGCAACGGCCTCGAGGGCACGCTGATCGAGGGCGAACTGCCCGAGCCCAAGAAGGTCAAGCCGCCCCGCACCCACTGGGACATGCTGCTGGAGCGCCGCTCGGTGGAGGAACTCGAGGAACTGCTCAAGGAGCGCCTCGATCTGATTAAGACAAAGCGTCGCGGCTGA	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTENGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGELPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKTKRRG	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGDVPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKAKRRGTGS	97.37	gnl|BL_ORD_ID|1341|hsp_num:0	1425		
k141_7062_1 # 2 # 172 # 1 # ID=7052_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.351	k141_7062_1 	2	172	+	Strict	750	100.5	mefC	100.0	3003745	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	AGTTTGGCAGTTTTGCCAAGTGTAATCGGTTTATTATTCACAGGCCTGATTGCAGAAGTTATTGGTGTAAACATTACGTTTATCATAAGCGGTTGTTTGGCAATCCTTGTGGGTATTCTTTCGTTTAGCACTCGCAACTTAATGCAATTAGGTAAAATCAAAAATATTTAA	SLAVLPSVIGLLFTGLIAEVIGVNITFIISGCLAILVGILSFSTRNLMQLGKIKNI	MENRKWFKTYMFIWAGQFASMLTSYAVQFAIVIWLSLEYKSAEVLAYAGIAAMLPQALIGLIAGVYVDRLNRKYVMIFSDAFIALCALLLLVILQNENVNLIWIYILLGLRSVGNAFHAPALQAIAPLIVPQNELIKVAGINQVLHSVCRIGGPAIGTLAIAYLPISKVLYLDLIGALLAILSLVMVKIPNVVAKSKSSAHSIATEFSEGFQTVSKNKGLRYLFLYAMAITFVIMPAAIMFPLLTTGHFAGGKWEIGIVEVVWGGGMLIGGVILSIFKLKGSKVVAVNVMYVLLGLTFILSGVLPASWFVGFVMVTAIGGISLSVFNGCFTAIVQTEVSPEKLGRVFSLYYSLAVLPSVIGLLFTGLIAEVIGVNITFIISGCLAILVGILSFSTRNLMQLGKIKNI	13.76	gnl|BL_ORD_ID|2102|hsp_num:0	2262	True	loose hit with at least 95 percent identity pushed strict
k141_7062_2 # 177 # 323 # 1 # ID=7052_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.340	k141_7062_2 	177	323	+	Strict	500	103.6	mphG	100.0	3003742	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAAAAATAGAGATATTCAAAAATTAGCGGAAAGAAATGGGTTAATTCTTTCGGATGAAATGAGTTTTAATGAAATGGGAATTGATTTTAAGGTTGGTTTCGCTACAGATAGGGATGGCACAAAGTGGTTGTTGCGTATTCCAAGA	MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPR	MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPRRTTLGEQIANEKRILQLVSKYLSVQVPDWRIANEKLVAYPLLDGKPALTYDAETYEVTWNMSKENDLYIPSLAKALIELHSIPTEEVLRNNLKILTPEQVRNEISERLILVKSELGINAELELRYQKWLDNDALWPNFTKFIHGDLYAGHTLTHHNGEVCGIIDWSTAQVSDIAQDFSGHVTVFGEESLKNLIAAYEKQGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGVE	16.67	gnl|BL_ORD_ID|2089|hsp_num:0	2259	True	loose hit with at least 95 percent identity pushed strict
k141_25873_2 # 425 # 3583 # 1 # ID=25836_2;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=8bp;gc_cont=0.404	k141_25873_2	425	3583	+	Strict	750	831.6	adeF	44.62	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTGAGTTTTTTATAAGAAGACCCATCTTCGCCATCGTTATTTCTATTTTGATCGTGATCATGGGGCTATTGACTATGTTGGGCATACCTGTGTCAAAATACCCAGAGATTACACCGCCGATGGTGCAAGTGACGGCTTTCTACAATGGTGCCAATGCAGTGAACATGGAGCAGGCTGTTGCAACTCCATTGGAACAGCAAATCAATGGTGTTGAGGGGATGTTGTACATGAAATCTATCAATGCGAACAATGGATCAACGTCTATACAGGTTTCATTTGATGTGGGTACCGACCTTGATAAAGTCAACATGCTTACGCAAAACAAAGTAGCGGCAGCAACTCCTTTCCTTCCAGCAGAAGTAAAGAACATTGGTGTGAACGTAAAAAAGTCACTCACCTTCCCTTTGGTACTGGTGTCGATGTATTCAAAGACTGGCGTATATGATGCTTCTTTTATCAATAATTATGCTTTCATCAATGTATTGGATGAATTAAAAAGAATAAAAGGTGTTGGTGATGTGGCTGTGATGGGTGGAGCTGAATATGCCATGCGTGTTTGGGTAAAGCCCGATCGTTTGGCTGCATTGAATATAACGGTGAATGATGTAATCAATGCAATGCGTGAGCAGAACAACATCATGCCAGGAGGAACCTTTGGTGATCAACCTGCTGGAGCTGATGTTAGGAATACTTATACTGCTTTATTGCAATCGCGTTTGGTTTCTGAAGAGCAGTTTGGCAATATAGTTTTAAAATCAAATAGCAATGGCGCACAAGTTAGATTGAAAGATGTGGCTCGTGTTGAGTTAGGTTTGCAGTCGTACAATGTGAGCAGCTACATGGATGGCTTTCCAAGTTCTACAATTGCTGTTTATCAGATTCCAGGTTCTAATGGTATTGAGGTGGCCAATCAGGTAAGAAAGAAAATGGATGAAATTAATGCCAGGTTTCCACAAGGGTTAGAGTATAAATTTTCTCTGGATACTACAGAAGCCATTACGGCAGGTATTGATGAAATTATGCATACATTGTTTGAGGCAGTGTTGTTGGTAATCTTGGTAGTATTCTTGTTCTTGCAAGATTGGAGAGCGACTTTAATTCCATTACTGACGGTTCCTGTATCATTGATCGGAACATTCATGATTTTCCCATTGTTGGGTTTTTCAATCAATACACTTTCGTTATTGGGCATGGTGTTAGCGATTGGATTGGTAGTAGATGATGCCATTGTAGTTGTTGAAGCGGTAATGCATCATTTAGAACATGGATTGTCGCCTAAAGAAGCGACAAAGAAAGCAATGAAAGAAGTAGGCGGACCAGTAGTTGCAATTGCAGTTATTCTTTGTGCTGTATTTATTCCTGTTGCATTGTCTGGTGGGATTACCGGTAGATTATATCAACAGTTTGCAATTACGATTGCTATATCAGTTGCTTTCTCTGCTTTTAATGCATTGACATTGAGTCCAGCGCTTGCAGCTATTTTGTTGAAACCACCAACCCAGAAAAAAGGTGCGTTGGCAAGATTCTTTGCTGCGTTTAATCGCATGTTTGATAAGCTGACTTTCGGTTACGCCAAAGTAGCTGGATTTGCAGCAAGAAAACTTGTATTTACAATTGGTATTCTTTTGGTGATTGTTTTCACAACAGGTGTTTTGGGTAAGTCGGTTAAATCAGGATTCCTTCCTGAAGAAGACGAAGGATATTTCTTGATGGCGATTCAATTGCCTGATGCTGCTTCATTAAACAGGACAGAGGCCGTTAGTACAAAAGTGCAAAAGCTCTTGTCAAAAGTTGAAGGCATTGAATCAGTTGCCATCATCAATGGATTTGATTTGTTGTCTGGTACAGCTAATCCAAATACAGCGACAGCCTTCATGGTATTAGAACCATGGGAAGAGCGTGAGCACAAGGCTTCTGAATTAATTAAAAAAGCGAATGCTTTAATGGCGAAAGAAGTTACAGATGGAACAGCGTTTGCTTTTGGTCCACCACCCATTCCAGGTTTAGGTAGTTCAGCTGGATTTAGTTTAATGTTGCAAGACAGAGGTGGGAAATCACCGGAGTATTTGGCAGAACAAACCAATAGTTTTATTGCAGCTGCATCCAAGCGTCCTGAAATTGGAAGAATAACTACATTCTATCGTTCCAACACACCACAAAAAAGTATACAAGTAGATGAAGACAAAGTAGAAAAACTCAATATGAGTTTATTGGAAGTGAACGGTAGTATTTCTGCATTGTTGGGGGGAAGTTTTGTCAATAATTTCAATGCATTTGGCAGACAGTACCGTACATATGTTCAAGCAGATGCACAATACAGAAGCAAGCCAGAAGATTTAGCGATGTTCTTTGTGAGAGATAACAAAGGGCAAATGATCAATCTTTCTACACTAGTGAAAGTGAAAGACACATCAGGGCCATTATTCACCAATCACTTTAATATATATCGTGCAGCTGAAATTACAGGTGCACCTGCTCCGGGATATAGTTCGGCAGATGCTTTGAATGCTTTAGAAGAAGTGGCAAAAGAAACATTGCCATCAGACATGGGTTTTCAGTGGAGCAATCTTTCTTATCAAGAAAAAGAAGCTGGCGGAAAATCTTCGACTGCATTTTTAATGGCCTTGGTGTTTGTGTTTTTGATTCTTGCTGCTCAATATGAGAGTTGGAAATTACCATTTAGCGTTTTGTTAGGAACACCTTGGGCGGTGATGGGAGCATTATTGGGTTTATATATAGGTGGATTATTTGCAGCTACTTATGTCAACAATATTTTTGCACAGATTGGCTTGGTGATGTTGATTGGTTTGAATGCGAAAAATGCTATTCTTATTGTCGAGTTTGCAAAACTCAAAATGGATGAAGAGGGGGTACCTGCATTACAGGCTGCTATTGAAGGAGCCAAGTTGAGGTTCAGGCCAATCCTCATGACATCATTAGCCTTCATATTAGGTGTTGTGCCTTTGTTAACCGCTACTGGCGCAGGATCAGAAGCGAGGAGAGTAATGGGTACGACAGTATTCAGTGGTATGGTTGTTGCCACCATAGTAGGCGTAATTCTAATTCCGGCATTGTTTGTTTTAATAGAAGGTAGAAAGAAAGTGCAGCCTATCGTGAAAGAGGCATCACCATCAAATTCAGCTGAACATGAGTAA	MSEFFIRRPIFAIVISILIVIMGLLTMLGIPVSKYPEITPPMVQVTAFYNGANAVNMEQAVATPLEQQINGVEGMLYMKSINANNGSTSIQVSFDVGTDLDKVNMLTQNKVAAATPFLPAEVKNIGVNVKKSLTFPLVLVSMYSKTGVYDASFINNYAFINVLDELKRIKGVGDVAVMGGAEYAMRVWVKPDRLAALNITVNDVINAMREQNNIMPGGTFGDQPAGADVRNTYTALLQSRLVSEEQFGNIVLKSNSNGAQVRLKDVARVELGLQSYNVSSYMDGFPSSTIAVYQIPGSNGIEVANQVRKKMDEINARFPQGLEYKFSLDTTEAITAGIDEIMHTLFEAVLLVILVVFLFLQDWRATLIPLLTVPVSLIGTFMIFPLLGFSINTLSLLGMVLAIGLVVDDAIVVVEAVMHHLEHGLSPKEATKKAMKEVGGPVVAIAVILCAVFIPVALSGGITGRLYQQFAITIAISVAFSAFNALTLSPALAAILLKPPTQKKGALARFFAAFNRMFDKLTFGYAKVAGFAARKLVFTIGILLVIVFTTGVLGKSVKSGFLPEEDEGYFLMAIQLPDAASLNRTEAVSTKVQKLLSKVEGIESVAIINGFDLLSGTANPNTATAFMVLEPWEEREHKASELIKKANALMAKEVTDGTAFAFGPPPIPGLGSSAGFSLMLQDRGGKSPEYLAEQTNSFIAAASKRPEIGRITTFYRSNTPQKSIQVDEDKVEKLNMSLLEVNGSISALLGGSFVNNFNAFGRQYRTYVQADAQYRSKPEDLAMFFVRDNKGQMINLSTLVKVKDTSGPLFTNHFNIYRAAEITGAPAPGYSSADALNALEEVAKETLPSDMGFQWSNLSYQEKEAGGKSSTAFLMALVFVFLILAAQYESWKLPFSVLLGTPWAVMGALLGLYIGGLFAATYVNNIFAQIGLVMLIGLNAKNAILIVEFAKLKMDEEGVPALQAAIEGAKLRFRPILMTSLAFILGVVPLLTATGAGSEARRVMGTTVFSGMVVATIVGVILIPALFVLIEGRKKVQPIVKEASPSNSAEHE	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	99.34	gnl|BL_ORD_ID|138|hsp_num:0	153		
k141_45875_12 # 16715 # 19897 # 1 # ID=45801_12;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.542	k141_45875_12	16715	19897	+	Strict	750	958.4	adeF	48.82	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTTTCTCGTTTCTTTATCGATCGTCCGATTTTTGCAGCGGTCATTTCGATCCTGATCACGTTGGCTGGGTTGGTTTTCGTTTGGCAGTTGCCGATCGCACAGTATCCAGAGATTACCCCGCCGACGGTGCAGGTATCTTGTATGTACCCTGGAGCCAGTGCATCGGTGGTTTCCGAGACGCTCGCCGCTCCGATCGAGCAGCAGATTCTCGGAGTCGAGAACATGCTATACATGTCCACGCAGTGCACCAATGACGGGGGGTGTTCGATCAGCGTTACCTTTGAGGTCGGTACCGATTTGGACATGGCCCAAGTCTTGGTGCAGAACCGGGTCAATTTAGCGACACCGAGTCTTCCGAGCGAAGTCAAGCAGACGGGCGTATCGGTCAAGAAGCGGTCGCCGAGTATCTTGTTGGTTGTGAATTTGATTTCGCCGGATGATACCCGAAGCCAGCTTTACTTGAGCAATTACGCTTCGATTCAACTGCGGAACGAGCTTGTTCGGGTGCCTGGAGTTGGCGACATCGGATTTCTCGGCCAGCTCGATTACTCGATGCGCGTGTGGCTCGATCCGAGCCGAATGGCAGCCTTAGGCATTACCGCCAGCGACGTGATGCAGTCGCTTCGAGAGCAGAATATCCAGGTGGCCGCCGGTTCGTTAGGACGCGAGCCGATGCTTCCTGGACAGGACTTTCAGTATACGCTATCGACGAAAGGTCGCTTGATCGAGCCTTCGGAGTTCGGCGGGATTGTCATCGGAACGAACCTGTCGGGAATCCCTGTTTATCTTAGGGATGTTGTCACCGAGCCGAGGCTCGGGAGCGATTCGCGAAGCTACGGTGGTATCGAGCTAGGAGCTAAGAATCAAGACACCTCTTGCACGTTGGATGGCAAGCCATCGATCGGTATGGCGATCTACCAACAGCCAGGTTCCAATGCGATCGATACGGCTCGGATGATTCAAGAGAAGATGGATGCGCTCAAGGCGAGTTTTCCGCCGGGGGTCGACTACAAGATCGTCTATGACACGACTCCCTTTATTTCCGAATCGATCATGGAGGTGTTCAAAGCGCTTCGGGATGCGATCTTGCTTGTGGCTATCGTCGTCCTGGCATTTCTTCAATCCTGGCGGGCCAGTGTGATTCCGTTGATCGCTGTCCCGGTGGCCATCATCGGTACGTTTGCGGTGATGCACGGGATCGGGTACAGCTTGAACAATCTTTCTCTTTTTGGTTTGGTGTTGGCCATCGGCATCGTCGTCGACGATGCGATTGTGGTCGTCGAGGCCGTCGAGCACCATCTCGAGCATGGCATGGAACCTCGCCAAGCGGCGATCAAGGCGATGGAGGAGGTCTCCGGGCCGATCATCGCGATTTCATTGGTCCTGATGTGTGTTTTCGTGCCGTGCATCTTTATCACAGGAATCACGGGGCAATTCTTCAGGCAGTTTGCAGTCACCATCGCCGTTTCGACGTTCTTCTCGGCGGTCAACTCGTTGACGCTCAGTCCGGCGCTCTGTGCGGTGCTTTTGAAGCCCAAGGCACAGCAGAACGATCCGTTGTCGAAACTGATGAAGTTCTCCCTGGGGTGGTTCTTTAGTCTCTTTAATCGGTTTTTTTCTTGGAGTTCGAACCTTTACGCAGGGACTGTCGGTCGGTTGCTCACCGGCCGTGCGGTCGTCATGGCGCTCTATATGGGGCTTTTGTACTGGACCTATTTCAGTATGACCCATACCCCCACAGGCTTTATTCCGCCGCAGGACAAAGGGTACTTGCTGGTCGATTTGCGGCTTCCTGATTCCGCATCGATCGAGCGGACTGGACGGACGTTGGGCCAATTCGAGAAGATTGTCCAAGAGATACCGGGGGTCGAGCACACCATTGGAGTCACAGGGCAATCTTTTGTTCAGAATGCAGTCGGTTCGAATTTCGGGAGTATGTTTATCATTTTGGAGCCATTCCACGATCGCAAGTCGATCGAGACGAAGGCACAAACGATCGGGGGTCGGATCCGCGAGCTGAGCTTTCGCGAGATCGACGAGGGGGTGTTCAGTGTCTTTGGTCCGCCTCCGGTCGATGGGATCGGCAGTGCAGGGGGGTTCAAGCTGATGCTGCGTGACACCGGGAATCTCGGTTACGAGACGCTCCAATCGGTTGCCGACGATGTCAGTGGCCAGTCGAGTCAGGCGCCGGGGATCCTAGGCATGTTCAATGGATTCCGTTCCAATACGCCTCAGATGTTTGTCGACATCGATCGAGAAAAAGTCAAAACGCTCGGTATTCCGTTGCAGGATGTTTTCACGACGCTTCAGGTTCAACTCGGGGGAGCTTACGCAAACGATTTCAATCAGTTTGGCAGGACATGGCAAGTCAACGTGCAAGCCGATCCGGAGTATCGCAGGAGCCCTGAGCAGGTTGGTCAGTTTCGAGTCCGCACGCTGTTGCGGCAGATGGTTCCATTAGCGACGTTTGCTACCGTTCGCGAGTCTCTCGGCCCATCGATGATCACTCGATACAACGGGGATGTAGCGGCACCTATCAACGGGATCACCGCACCGGGTCTGAGTTCCGGCGATATGGTCAAGAGCGTTCAAGGAGTACTCGACGAGAAATTGCCCGATGGGATCAAGTCGGAGTGGACGGAGTTGACCTATTTGCAACTCAAGGCTGGTAACACAGCGTTGTTGGTATTTGCGATGGCTGTCGTATTGGTTTTTTTGGTGTTGGCGGCACAGTACGAGAGTTTGGTTCTTCCGCTGTCGGTGATTCTCGTAGTGCCGATGTGCTTGCTCTGCTCGGTTCTTGGAATCGGGATGGTAGGTTTGGATATCAACATTTTCGTCCAGATTGGATTTGTGGTTTTGGTGGGTTTGGCCAGCAAAAACGCGATCTTGATAGTCGAGTTTGCCAAGCAGCTTCAGGAGTCTGGAAAGACGCCGCGGGAAGCTACAATCGAGGCATGCCGGATGCGGCTACGACCGATCTTGATGACATCCTTTGCATTCATCTTGGGTGTGGTGCCGCTGGTTTTGGCCGAGGGTGCTGGGGCCGAGATGCGCAAGACCTTGGGCATCGCGGTATTTGCGGGGATGCTCGGCGTGACGTTCTTTGGGATCTTTCTAACGCCGGTCTTTTACTTTTTGGTCGCGGGTGTCGTTAAGTCAAAAAAGACCGACTCATGA	MLSRFFIDRPIFAAVISILITLAGLVFVWQLPIAQYPEITPPTVQVSCMYPGASASVVSETLAAPIEQQILGVENMLYMSTQCTNDGGCSISVTFEVGTDLDMAQVLVQNRVNLATPSLPSEVKQTGVSVKKRSPSILLVVNLISPDDTRSQLYLSNYASIQLRNELVRVPGVGDIGFLGQLDYSMRVWLDPSRMAALGITASDVMQSLREQNIQVAAGSLGREPMLPGQDFQYTLSTKGRLIEPSEFGGIVIGTNLSGIPVYLRDVVTEPRLGSDSRSYGGIELGAKNQDTSCTLDGKPSIGMAIYQQPGSNAIDTARMIQEKMDALKASFPPGVDYKIVYDTTPFISESIMEVFKALRDAILLVAIVVLAFLQSWRASVIPLIAVPVAIIGTFAVMHGIGYSLNNLSLFGLVLAIGIVVDDAIVVVEAVEHHLEHGMEPRQAAIKAMEEVSGPIIAISLVLMCVFVPCIFITGITGQFFRQFAVTIAVSTFFSAVNSLTLSPALCAVLLKPKAQQNDPLSKLMKFSLGWFFSLFNRFFSWSSNLYAGTVGRLLTGRAVVMALYMGLLYWTYFSMTHTPTGFIPPQDKGYLLVDLRLPDSASIERTGRTLGQFEKIVQEIPGVEHTIGVTGQSFVQNAVGSNFGSMFIILEPFHDRKSIETKAQTIGGRIRELSFREIDEGVFSVFGPPPVDGIGSAGGFKLMLRDTGNLGYETLQSVADDVSGQSSQAPGILGMFNGFRSNTPQMFVDIDREKVKTLGIPLQDVFTTLQVQLGGAYANDFNQFGRTWQVNVQADPEYRRSPEQVGQFRVRTLLRQMVPLATFATVRESLGPSMITRYNGDVAAPINGITAPGLSSGDMVKSVQGVLDEKLPDGIKSEWTELTYLQLKAGNTALLVFAMAVVLVFLVLAAQYESLVLPLSVILVVPMCLLCSVLGIGMVGLDINIFVQIGFVVLVGLASKNAILIVEFAKQLQESGKTPREATIEACRMRLRPILMTSFAFILGVVPLVLAEGAGAEMRKTLGIAVFAGMLGVTFFGIFLTPVFYFLVAGVVKSKKTDS	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	100.09	gnl|BL_ORD_ID|138|hsp_num:0	153		
k141_88548_1 # 219 # 1058 # 1 # ID=88381_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.617	k141_88548_1	219	1058	+	Perfect	500	549.7	sul1	100.0	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGTGACGGTGTTCGGCATTCTGAATCTCACCGAGGACTCCTTCTTCGATGAGAGCCGGCGGCTAGACCCCGCCGGCGCTGTCACCGCGGCGATCGAAATGCTGCGAGTCGGATCAGACGTCGTGGATGTCGGACCGGCCGCCAGCCATCCGGACGCGAGGCCTGTATCGCCGGCCGATGAGATCAGACGTATTGCGCCGCTCTTAGACGCCCTGTCCGATCAGATGCACCGTGTTTCAATCGACAGCTTCCAACCGGAAACCCAGCGCTATGCGCTCAAGCGCGGCGTGGGCTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGGCTGGTGGTTATGCACTCAGCGCAGCGGGATGGCATCGCCACCCGCACCGGTCACCTTCGACCCGAAGACGCGCTCGACGAGATTGTGCGGTTCTTCGAGGCGCGGGTTTCCGCCTTGCGACGGAGCGGGGTCGCTGCCGACCGGCTCATCCTCGATCCGGGGATGGGATTTTTCTTGAGCCCCGCACCGGAAACATCGCTGCACGTGCTGTCGAACCTTCAAAAGCTGAAGTCGGCGTTGGGGCTTCCGCTATTGGTCTCGGTGTCGCGGAAATCCTTCTTGGGCGCCACCGTTGGCCTTCCTGTAAAGGATCTGGGTCCAGCGAGCCTTGCGGCGGAACTTCACGCGATCGGCAATGGCGCTGACTACGTCCGCACCCACGCGCCTGGAGATCTGCGAAGCGCAATCACCTTCTCGGAAACCCTCGCGAAATTTCGCAGTCGCGACGCCAGAGACCGAGGGTTAGATCATGCCTAG	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	100.00	gnl|BL_ORD_ID|1006|hsp_num:0	1070		
k141_102499_3 # 1183 # 1518 # 1 # ID=102303_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.658	k141_102499_3	1183	1518	+	Strict	200	222.6	RbpA	95.5	3000245	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	RbpA bacterial RNA polymerase-binding protein	ATGGCTGATCGTGTGCTCAGGGGCAGCCGGCTCGGAGCTGTGAGCTACGAGACCGACCGCAATCACGACCTCGCGCCGCGTCAGGTCGCGCGCTACCGCACCGAGAACGGCGAGGAGTTCGACGTCCCGTTCGCCGATGATGCCGAGATCCCCGGCACCTGGCTGTGCCGCAATGGCCTCGAGGGGACGCTGATCGAGGGCGAACTGCCCGAGCCCAAGAAGGTCAAGCCGCCCCGTACCCACTGGGACATGCTGCTGGAACGCCGCTCGGTGACCGAACTCGAGGAACTGCTCAAGGAGCGGCTCGATCTGATTAAGACGAAACGCCGCGGCTAG	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTENGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGELPEPKKVKPPRTHWDMLLERRSVTELEELLKERLDLIKTKRRG	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGDVPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKAKRRGTGS	97.37	gnl|BL_ORD_ID|1341|hsp_num:0	1425		
k141_122067_1 # 1 # 303 # -1 # ID=121834_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.637	k141_122067_1 	1	303	-	Strict	2200	207.2	rpoB2	96.04	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	TTCCCGTACCCGGTGACGGTCGGCTACATGTACATCCTCAAGTTGCACCACCTGGTGGACGACAAGATCCACGCCCGTTCCACCGGCCCGTACTCGATGATCACCCAGCAGCCACTGGGCGGTAAGGCGCAGTTCGGCGGCCAGCGGTTCGGTGAGATGGAGTGCTGGGCCATGCAGGCCTACGGCGCGGCCTACACGCTGCAGGAACTGCTGACCATCAAGTCCGACGACACCGTCGGCCGGGTCAAGGTCTACGAGGCGATCGTCAAGGGCGAGAACATCCCCGAACCCGGTATCCCGGAG	FPYPVTVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPE	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	8.69	gnl|BL_ORD_ID|2492|hsp_num:0	2831	True	loose hit with at least 95 percent identity pushed strict
k141_185573_1 # 1 # 240 # 1 # ID=185215_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.650	k141_185573_1 	1	240	+	Strict	420	159.8	mtrA	98.73	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GAGCAGATCTCGTTGACCCCGCTGGAGTTCGACCTTCTGGTCGCGTTGGCGCGCAAACCGCGGCAGGTGTTTACTCGTGATGTGCTGCTCGAGCAGGTGTGGGGTTACCGTCACCCCGCGGACACCCGGCTGGTGAACGTGCATGTCCAGCGGCTGCGGGCCAAGGTCGAGAAGGACCCGGAGAACCCGCAGGTGGTGCTGACCGTTCGAGGAGTGGGTTACAAGGCGGGGCCCCCGTAA	EQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPQVVLTVRGVGYKAGPP	MDTMRQRILVVDDDASLAEMLTIVLRGEGFDTAVIGDGTQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYIMKPFKPKELVARVRARLRRNDDEPAEMLSIADVEIDVPAHKVTRNGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPTVVLTVRGVGYKAGPP	34.65	gnl|BL_ORD_ID|1467|hsp_num:0	1559	True	loose hit with at least 95 percent identity pushed strict
k141_289586_1 # 463 # 1017 # -1 # ID=288068_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.586	k141_289586_1	463	1017	-	Strict	275	318.5	AAC(6')-32	83.15	3002586	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCTCTCAGCCAATGAACCCTTGACGCTGCGGCTCATGACTGAGCAAGATCTACCCATGCTCCACGAGTGGCTCAACCGGCCCCACATTGTGGAGTGGTGGGGCGGAGAGGAAGCGCGTCCGACGCTTGAGGAAGTTCAGGAACACTATCGACCAAGGGTCCTCGCGGAAGAGTCCGTGACCATGTACATCGCTATGCTGGCTTCGGAACCCATTGGCTTTGCACAGTCGTACGTTGCACTGGGTTCCGGCGACGGATGGTGGGAGAACGAGACCGACCCAGGTGTCCGAGGAATCGACCAATCGCTGGCCAACGCGATGCAGTTGAACCAGGGCCTCGGTACCAAAATGGTCCAGGCGCTGGTCGAGTTGCTCTTCTCTGATCCAGCAGTCACAAAGATCCAAACTGATCCCGCGCCAAACAACCTGCGAGCCATCCGCTGCTACGAGAAGGCTGGGTTTACCCAGGAGCAGGTCATCACAACCCCAGATGGCCCAGCTGTGTACATGACCCAGACCAGACAAGCCTTCGAGCGTGCGCGCAGTGCTGCCTAA	MLSANEPLTLRLMTEQDLPMLHEWLNRPHIVEWWGGEEARPTLEEVQEHYRPRVLAEESVTMYIAMLASEPIGFAQSYVALGSGDGWWENETDPGVRGIDQSLANAMQLNQGLGTKMVQALVELLFSDPAVTKIQTDPAPNNLRAIRCYEKAGFTQEQVITTPDGPAVYMTQTRQAFERARSAA	MSPSKTPVTLRLMTERDLPMLHAWLNRPHIVEWWGGEEERPTLHEVVKHYLPRVLAEEAVTPYIAMLGDEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQFLSNHTQLNQGLGTKLVQALVELLFSDPTVTKIQTDPAPNNHRAIRCYEKAGFVQQNVITTPDGPAVYMVQTRQAFERVRSAA	100.00	gnl|BL_ORD_ID|1483|hsp_num:0	1577		
k141_289964_2 # 751 # 1086 # 1 # ID=288410_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.640	k141_289964_2	751	1086	+	Strict	200	223.4	RbpA	95.5	3000245	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	RbpA bacterial RNA polymerase-binding protein	ATGGCTGATCGTGTGCTGAGAGGCAGCCGCCTCGGCGCCGTGAGCTACGAGACCGACCGCAACCACGACCTCGCACCCCGGCAGGTGGCCCGTTACCGCACCGACAATGGCGAAGAGTTCGAAGTTCCGTTCGCCGACGACGCCGAGATTCCGGGTACCTGGTTGTGCCGCAACGGCCTTGAGGGCACCCTGATCGAGGGTGAGATTCCCGAACCGAAGAAGGTCAAACCACCCCGGACGCACTGGGACATGCTGCTGGAGCGCCGCTCGGTCGAGGAGCTCGAGGAGCTACTCAAAGAACGCCTGGAGCTGATCAAGACAAAGCGCCGCGGCTGA	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFEVPFADDAEIPGTWLCRNGLEGTLIEGEIPEPKKVKPPRTHWDMLLERRSVEELEELLKERLELIKTKRRG	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGDVPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKAKRRGTGS	97.37	gnl|BL_ORD_ID|1341|hsp_num:0	1425		
k141_341438_4 # 1744 # 2082 # 1 # ID=333202_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.640	k141_341438_4	1744	2082	+	Strict	200	221.1	RbpA	91.96	3000245	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	RbpA bacterial RNA polymerase-binding protein	ATGGCTGATCGTGTGCTGAGAGGCAGCCGACTTGGCGCCGTGAGCTACGAGACCGACCGCAACCACGACCTGGCGCCGCGGCAGCTCGCGCGGTACCGCACCGAAAACGGTGAGGAATTCGAGGTTCCGTTTGCCGACGACGCCGAGATTCCGGGAGCGTGGCTGTGCCGCAACGGACTTGAGGGAACCCTCATTGAGGGCAACATCCCGGAGCCGAAGAAGGTCAAGCCACCCAGGACGCACTGGGACATGCTGCTGGAGCGTCGCTCGGTCGAGGAACTCGACGAGTTGCTCAAGGAACGGCTCGACCTGATCAAGACCAAGCGCCGCGGCAGCTGA	MADRVLRGSRLGAVSYETDRNHDLAPRQLARYRTENGEEFEVPFADDAEIPGAWLCRNGLEGTLIEGNIPEPKKVKPPRTHWDMLLERRSVEELDELLKERLDLIKTKRRGS	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGDVPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKAKRRGTGS	98.25	gnl|BL_ORD_ID|1341|hsp_num:0	1425		
k141_423069_1 # 1 # 492 # 1 # ID=402138_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.413	k141_423069_1 	1	492	+	Strict	750	303.5	mefC	99.39	3003745	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	CCGGCACTACAGGCAATTGCTCCGCTGATTGTACCCCAAAATGAATTGATAAAGGTAGCAGGAATTAATCAGGTGTTACATTCGGTTTGCAGTATTGGTGGTCCTGCCATTGGCACATTAGCCATTGCTTATCTTCCTATTTCAAAAGTATTGTACTTGGATTTGATTGGAGCATTGCTGGCTATTCTTTCACTCGTGATGGTGAAAATTCCCAATGTGGTTGCGAAGTCAAAATCGTCTGCACATTCTATTGCTACAGAATTTTCGGAAGGGTTTCAGACTGTTTCAAAAAACAAAGGTTTGCGTTATCTTTTTCTTTATGCAATGGCGATAACCTTTGTTATAATGCCAGCTGCCATTATGTTTCCGTTGCTCACAACAGGGCATTTTGCAGGAGGAAAATGGGAGATAGGAATTGTAGAAGTGGTTTGGGGCGGAGGTATGCTTATTGGCGGTGTCATCCTGAGTATTTTCAAATTGAAAGGCTCAAAA	PALQAIAPLIVPQNELIKVAGINQVLHSVCSIGGPAIGTLAIAYLPISKVLYLDLIGALLAILSLVMVKIPNVVAKSKSSAHSIATEFSEGFQTVSKNKGLRYLFLYAMAITFVIMPAAIMFPLLTTGHFAGGKWEIGIVEVVWGGGMLIGGVILSIFKLKGSK	MENRKWFKTYMFIWAGQFASMLTSYAVQFAIVIWLSLEYKSAEVLAYAGIAAMLPQALIGLIAGVYVDRLNRKYVMIFSDAFIALCALLLLVILQNENVNLIWIYILLGLRSVGNAFHAPALQAIAPLIVPQNELIKVAGINQVLHSVCRIGGPAIGTLAIAYLPISKVLYLDLIGALLAILSLVMVKIPNVVAKSKSSAHSIATEFSEGFQTVSKNKGLRYLFLYAMAITFVIMPAAIMFPLLTTGHFAGGKWEIGIVEVVWGGGMLIGGVILSIFKLKGSKVVAVNVMYVLLGLTFILSGVLPASWFVGFVMVTAIGGISLSVFNGCFTAIVQTEVSPEKLGRVFSLYYSLAVLPSVIGLLFTGLIAEVIGVNITFIISGCLAILVGILSFSTRNLMQLGKIKNI	40.29	gnl|BL_ORD_ID|2102|hsp_num:0	2262	True	loose hit with at least 95 percent identity pushed strict
k141_427604_2 # 832 # 3990 # 1 # ID=406663_2;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.667	k141_427604_2	832	3990	+	Strict	750	1023.1	adeF	52.44	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGGTTCGCCCACTTCTTCATCGACCGTCCCATCTTCGCGACGGTGCTCTCGGTCGTCGTGCTGATCGTCGGGGGCTTGAGCTACTTCTCCCTGCCGGTGTCGCAATATCCAGAGATTGCCCTGCCGACGGTGGTCGTCACCGCCGGCTACCCCGGGGCCACGGCCGAAACCGTCGCCGAGACGGTCGCCACGCCCCTGGAGCAGGAGATCAACGGTGTCGAAAACATGCTCTACGTCGAGTCGCAGTCGACCGACGATGGCCAGCTGACGCTCACCGTCACGTTCGAACTCGGCACCGACATCGACCGCGCGCAGGTGCTCGTGCAAAATCGCGTGGCCCGCGCCGAGCCACGCCTCCCGGCCGAGGTGCGGCAGGCGGGCGTCGTGACGGCGAAGACGTCGCCCGAACTCCTGCTGGTCGTCCATCTCATCTCCCCCGACGCCTCCCGCGACCAGCTCTACATCGCCAACTTCGCCTACCTGCGGATTCGCGATGTGCTCGCCCGGCTCAACGGTATCGGCGAACTGCGGATCTTCGGCGGCTCGGAATACTCGATGCGGGTCTGGCTCGACATCGAGCGGCTCGCATCGCTCGATCTCACCGCCGGCGACGTCGTCGCGGCGTTGCGGGAGCAGAACGTCCAGGTGGCGGCCGGCAAGATCGGCCAGACGCCGCTACCCCATCCCGCCGACACGGAGCTCACGATCACGAGCCAGGGCCGCCTGAAGACCGCAGAGGAGTTCGCCGACATCGTCATCAAGCGGGGTGCCGACGGCCGGCTGGCCCGGCTCGCCGACGTGGCCCGGATCGAACTCGGCTCCCAGGATTATTCGGTCAACAGCTACCTCGACGGCAACAACGCCGTGGCCGTGCTCGTCTTCGCCCGCCCCGGCACCAACGGGGTCGAGACGGCCCACGCGGTGCAGCGGACGATGCGGGAGCTGCGGCCCGGTTTTCCCGCGGGGGTCGACTACACGATCGCGTATAACCCGACGCAGTTCGTCGAGGAATCGATTGCCGAGGTGTTTGAAACGCTGTTCGCGGCGACCGCGCTGGTCGTGCTCACCGTCTTCGTTTTCCTCCAGCGGTGGCAGGCCACGCTCATCCCGGTCGTCGCGATCCCAATCTCACTCGTCGGCACGTTCTCGGTGATGGCGGGGCTGGGCTTCAGCCTCAACAGCCTCTCGCTCTTCGGCCTCGTGCTGGCGATAGGCGTGGTCGTCGACGACGCCATCGTGGTCGTGGAAAACGTCGAGCGGCTCATCGCCGAGGGGATGCGGCCCAACGAGGCAACGAAGCTGGCGATGACCCAGGTCGGCTCGGCGCTCATCGCCACCACGCTCGTGCTGGTGGCCGTGTTCGTGCCGACCGCCTTCATCGGCGGGATCAGCGGCCAATTCTACCGCCAGTTCGCGATCACGATCGCCGTGGCGACCTGCTTCAGCACGTTCGTGTCGCTCACGCTCACGCCGGCAATGTGCGGCCTGCTCCTCCAGCCCGCCGATGCTCCGCGGTCGTCCATCACGCGGGTCATGGATCGGCTCTTCGGCTGGCTCTTCGTACCCTTCAATGTCGTTTTTACCTGGTCGAGCAATCTCTATGCCACGATCGTCGGGCGGATCGTACGACTCGGGTTCCTCATGCTCCTACTCTACGCCGGGCTGCTGGCGGCCACCGGAGCGAGTTTCAATCTCGTGCCCACTGGGTTCATCCCCGAGCAGGATCAGGGCTACCTGATCGTGGCGGCCCAGCTGCCCGATGGCGCATCGCTCTCCCGTACCGACGCCGTGGTGCGGCGGATCAGCGAGACGGCCCTCTCCATCGATGGTGTCAAAAACGCCGTGGCCTTCGCCGGCTTTTCCGGAGCGACGCGGACCAACGCTCCCAATGCCGCCGCCTGCTTCACGGCCCTGGAAGACGCCCGCACCCGGGCGGCCCGCGGCCGTTCGGTGGACGTGCTCCTGGCGGAGATGCAGGCCAAGCTCGGCGCCATCCAGGAGGCGCAGATCGTGGTGCTCGCTCCACCGCCGGTGCGGGGCATCGGCAATGCCGGCGGCGTGAAAATGTATGTGCAGGACCGCAGTGGCGCGGGCTATGCGGCGCTCGGGGAGGCTGCGGGCGAGATCGTGGGCACCGCACTCGGCCAACTCGGGCCGCAGAGCGGCCTGGCCTTCGCCACGAGCTTCTATCGATCGAAGACGCCCAAGCTCTATGCCGACATCGACCGCGTGCGCGCCCAGCAGCTCGATGTGCCGATGCGCAACGTCTTCGAGACGCTGCAGGTCTACCTCGGCTCGCTCTATGTCAACGACTTCAACTATCTCGGCCGCACCTATCGTGTCACGGCCCAGGCCGACGCACCCTTCCGCGACGAGGTGGAGGATGTGCTGCGGCTGCGCACGCGAAGCGCCTCCGGTGCGATCGTGCCGCTGGGCACGATTCTCACGATGCAGTCGCGGGTCGGGCCCGACCGCGTGATCCGCTACAACCTCTATCCGGCAGCCGACGTGCAGGGCGTGACACTCCCGGGAGCGAGCACCGGCTTGTCGATGACGTCGCTGGAGCGGATCGCCGACGACGCGCTCCCCCAAGGCTTCGCCTACGAGTGGACCGACCTCGCCTACCAGCAGAAACTGGCGGGGTCGACGGCGCTCTTCATCTTCCCGCTGTCGGTACTCTTCGTATTCCTCACGCTGTCGGCCCAGTACGAAAGCTGGACGCTGCCCCTGGCGATCATCCTGATCGTACCGCTGTGCCTCCTCTTTGCGTTGGTGGGCGTGTGGTTTCGGGGGATCGACAACAACGTGCTCACGCAGATCGGGTTCGTGGTGTTGATCGCGCTGGCCTGCAAAAACGCGATCCTCGTGGTCGAGTTCGCCAAGACGCTCGAGGACGAGGGCCGCGACCGGTTTGCGGCGGCGGTGGAGGCCTGCCGGATCAGGCTGCGGGCGATCCTGATGACCGCCTTTTCGTTTGTGCTCGGCGTGATCCCGCTCTTGGTGGCGACGGGAGCGGGGGCGGAGATGCGACGGGCGCTCGGCACGACGGTCTTCGCCGGAATGCTGGGCGTGACGCTGCTGGGCCTGTTCCTGACGCCCGTGTTCTACGTGTTCCTGCGGGGCCTCGTGGCGCGGCGGACCGATCGGCTACCATAG	MRFAHFFIDRPIFATVLSVVVLIVGGLSYFSLPVSQYPEIALPTVVVTAGYPGATAETVAETVATPLEQEINGVENMLYVESQSTDDGQLTLTVTFELGTDIDRAQVLVQNRVARAEPRLPAEVRQAGVVTAKTSPELLLVVHLISPDASRDQLYIANFAYLRIRDVLARLNGIGELRIFGGSEYSMRVWLDIERLASLDLTAGDVVAALREQNVQVAAGKIGQTPLPHPADTELTITSQGRLKTAEEFADIVIKRGADGRLARLADVARIELGSQDYSVNSYLDGNNAVAVLVFARPGTNGVETAHAVQRTMRELRPGFPAGVDYTIAYNPTQFVEESIAEVFETLFAATALVVLTVFVFLQRWQATLIPVVAIPISLVGTFSVMAGLGFSLNSLSLFGLVLAIGVVVDDAIVVVENVERLIAEGMRPNEATKLAMTQVGSALIATTLVLVAVFVPTAFIGGISGQFYRQFAITIAVATCFSTFVSLTLTPAMCGLLLQPADAPRSSITRVMDRLFGWLFVPFNVVFTWSSNLYATIVGRIVRLGFLMLLLYAGLLAATGASFNLVPTGFIPEQDQGYLIVAAQLPDGASLSRTDAVVRRISETALSIDGVKNAVAFAGFSGATRTNAPNAAACFTALEDARTRAARGRSVDVLLAEMQAKLGAIQEAQIVVLAPPPVRGIGNAGGVKMYVQDRSGAGYAALGEAAGEIVGTALGQLGPQSGLAFATSFYRSKTPKLYADIDRVRAQQLDVPMRNVFETLQVYLGSLYVNDFNYLGRTYRVTAQADAPFRDEVEDVLRLRTRSASGAIVPLGTILTMQSRVGPDRVIRYNLYPAADVQGVTLPGASTGLSMTSLERIADDALPQGFAYEWTDLAYQQKLAGSTALFIFPLSVLFVFLTLSAQYESWTLPLAIILIVPLCLLFALVGVWFRGIDNNVLTQIGFVVLIALACKNAILVVEFAKTLEDEGRDRFAAAVEACRIRLRAILMTAFSFVLGVIPLLVATGAGAEMRRALGTTVFAGMLGVTLLGLFLTPVFYVFLRGLVARRTDRLP	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	99.34	gnl|BL_ORD_ID|138|hsp_num:0	153		
k141_508446_2 # 453 # 3626 # -1 # ID=487305_2;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.677	k141_508446_2	453	3626	-	Strict	750	882.5	adeF	47.89	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATCTCGCGGTTCTTCATCCGGCGGCCGATCTTCGCGTCGGTGATCTCGATCGTGATCACGCTGGCCGGCGGGGTGAGCCTGCTCTCGCTGCCGATCTCGCTCTTTCCCCCGGTTGCGCCGCCGATCGTGCAGGTGTACTGCGCGTATCCGGGGGCGAATGCGGCGGTCGTGACCGACACGATCGCGGCGCCGATCGAGCAGCAGGTCAACGGCGTCGACAACCTGCTCTACATGCAGTCGCAGGCGACCAACGACGGCACCTACGTGCTTCAGCTCACGTTCGAGGTGGGGGCCGACGCCAACCTGGCCCTCGTGCAGACCCAGAATCGCGTCCAGCTCGCGATGCCGCTCCTGCCCCCGGTCGTGCAGATTCAGGGCGTGAGCGTCAAGAAGCGGTCGCCCGACATCCTGATGACGGTCGATCTGATTTCGCCCGACGGGCGGTACGACGATGTCTTCATGAGCAACTATGCCACGGTCCACCTGCGGGATGAACTGCTCCGCTGTCCCGGGGTCGGCGACATTCTCCTGCTCGGGCAACGAGACTATTCGCTGCGGATCTGGCTCGATCCCGAGCAGCTCGCCGCCCGGGGGCTGACCTCCCAGGAGGCCCGCGACGCGATCAAGGCCCAGAACGTGCAGGTGCTCGGGGGCGTCAGCGGCCAGTCTCCGGCCGCCGACGACCAGCAGCTGCAGTTGGCGGTCGCCGCCACCGGGCTGCGCTCCACGCCCGAGGAGTTCGGGGCGATCGTGCTCCGCGCCGATCCAACCGTGCCCGGAACGCCGCTGGTGCGGCTGCGGGACGTCGCCCGGATCGAACTCGGCGCGGCCGGCTACGACCAGACCTGCCGCTACAACGGAAAACTCGTGGTGGGGCTGGCCGTGTTCCAGCTCCCCGAAGCCAATGCGCTCGAAACCTCATGGGCCATCCAGGCGAAAATGGAGGAACTGGCCGCACGGTTTCCCGCCGGCCTCGACTACGTCATCGCCTACGACACGACCCCCTTCATCACGGAATCGATCGTCGAGGTGGTGAAGACGCTCCGCGATGCGATCCTGCTGGTCGGGCTTGTGGTGTTGCTGTTTCTTCAGAGCTGGCGGGCCACGCTGATTCCGCTCGTGGCGGTGCCGGTGGCGATCGTGGGCACGTTCGCCGCGATGGCGGCCATGGGCTTCAGCCTCAACACGCTGTCGCTCTTCGGCCTGGTGCTGGCGATCGGCATCGTGGTGGACGACGCGATCGTGGTGGTGGAGAACGTCGAACGCTGGATCAGCCAGGGGCTCGACTCCTACGCCGCGGCGGAGCGGGCGATGAGGGAGGTCACCGGCCCGGTGATCGGCGTGGCGGCGGTCCTCTCGGCGGTGTTCGTGCCCTGCGCGTTCATCGGCGGCGTGACCGGCCTCTTCTTCCGGCAGTTTGCCCTGACGATCGCGGTCTCGACGATTCTCTCGGCGGTCAACTCGCTCACCCTGAGCCCGGCCCTCGCGGCGATCCTGCTGCGGCCCCACGCCGCTCCCCCCGATCCGCTGGAGCGGCTCCTGGGCTGGGTGCTGGGGCCGGTGTTTTGGGTCTTCAACCGGTTCTTCGACGCGCTCACCACCGGCTATGCCCGGGGAGTCGCGGCCGTCGTCAGGCATGGACGCCTGGTGCTCGCCGCCTACCTGTTCCTGGTGTTCATCACCTGGCGGTTGTTCGCCGTCTATCCGCAGGGGTTCGTGCCACTGCAGGATCAGGGGTATCTGGTGGCCGGGGTGGAACTGCCCGACGGGGCATCGGTGCAACGCACGAGCGAGGTGCTCGCGCGGGTCGATGCCCTGGCCCACACCGTGCCCGGGATCGCCGACACCTTCACCGTGGCCGGAATGTCGCTGATCTACAACGCCAATGGGCCACACTGGGGCTCCCTCTTCCTGATGCTCGACGAGTATGAACACCGGCGCACCCCCGAGACCTCGATGTTTGGCATCATTGGGGAGCTGCGGGAGCGTTGCCGCCGGGAAATCCTGGACGCGGAAGTGGGCATCTACCCGCCGCCGCCGGTCAAGGGGATGGGGATGGCCGGAGGGTTCAAGTTCTACCTCCAGGATCGAGGCAGCCTGGGGCCCCAGGTGATGCAGGAGGCAAGCCAGAAACTCGTGGCCGAGATGGAGGGCTGGAAGCTGCCGTTCGTCGCCGGCGGCTACCGGGCCGATTCGCCGCAGTATTTCCTCGACATCGACCGCGACAAGATTCGCGGGCTCGGCATCCCGCTCTCGTCGGTCTTCACCGCCCTGCAGCTGGACGTGGGCTCGTTGACCGTCAACACCTTCAGCCGCTTCGGCCGCACCTGGCAGGTGAAGGTGATGGCCGACGAGGGCTTTCGACGCAGCCTCGAGGATCTCCGGGAGCTGAAGGTGGTGGCCCGCGACGGCGGGATGGTGCCCCTGGCTTCGGTCATGGAGGTTCGGCAGGCGATGGGCCCGGCGATCATGATGCGGTACAACCTCTACCCGGCGGCGCCGATCGTGGGGATCCCCAATCCCTTCGAGGGCGGGTCGGTGCTCATCGACCGCGTGGCCACCGCGGCCCGGGAGGAACTGCCCGAGAACTACTCCTATGAGTGGACGGAGGTGTTCCTCCTGCAGATCGCGGCGGGCAACACGGCGGGGCTGCTCTTGGGGCTGGGCGTGATCCTGGTGTTCCTCGTCCTGGCGGCGCTCTATGAGAGCTGGGCCCAGCCCCTGGCGGTGATTCTGGTCGTGCCCTTGTGCCTGCTGGCGGCCGTGGTCGGCCTGCTGCTCTCGTTTCTGCCGATCGACATCCTCGCCCAGGTGGGGCTCGTCGTGCTGGTGGGGCTGGCCTGCAAGAACGCGATCCTGATCGTGGAGTTTGCCCGCCAGCTGCATGCCGAGGGGCACGACGCCCGCTCGGCGGCGATCACCGCCAGCCGGCTGCGACTGCGGCCGATCCTGATGACCTCGCTGGCCTTCATTCTCGGGGTGGTGCCGCTGGTGATCGCCCGCGGGGCGGGGGCCGAACTCCGCTGGTCGCTGGGGGTCACCGTGTTTGCGGGCATGATCGGCGTGACGCTGTTCGGCATCTTCCTGACCCCGGTGTTCTACGAGAAGCTGACAGGCTTGAGCGACCGCTGGCAGGCCCGCGGCCCCGAACCGGAGGCGACCCGGCCATGA	MISRFFIRRPIFASVISIVITLAGGVSLLSLPISLFPPVAPPIVQVYCAYPGANAAVVTDTIAAPIEQQVNGVDNLLYMQSQATNDGTYVLQLTFEVGADANLALVQTQNRVQLAMPLLPPVVQIQGVSVKKRSPDILMTVDLISPDGRYDDVFMSNYATVHLRDELLRCPGVGDILLLGQRDYSLRIWLDPEQLAARGLTSQEARDAIKAQNVQVLGGVSGQSPAADDQQLQLAVAATGLRSTPEEFGAIVLRADPTVPGTPLVRLRDVARIELGAAGYDQTCRYNGKLVVGLAVFQLPEANALETSWAIQAKMEELAARFPAGLDYVIAYDTTPFITESIVEVVKTLRDAILLVGLVVLLFLQSWRATLIPLVAVPVAIVGTFAAMAAMGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERWISQGLDSYAAAERAMREVTGPVIGVAAVLSAVFVPCAFIGGVTGLFFRQFALTIAVSTILSAVNSLTLSPALAAILLRPHAAPPDPLERLLGWVLGPVFWVFNRFFDALTTGYARGVAAVVRHGRLVLAAYLFLVFITWRLFAVYPQGFVPLQDQGYLVAGVELPDGASVQRTSEVLARVDALAHTVPGIADTFTVAGMSLIYNANGPHWGSLFLMLDEYEHRRTPETSMFGIIGELRERCRREILDAEVGIYPPPPVKGMGMAGGFKFYLQDRGSLGPQVMQEASQKLVAEMEGWKLPFVAGGYRADSPQYFLDIDRDKIRGLGIPLSSVFTALQLDVGSLTVNTFSRFGRTWQVKVMADEGFRRSLEDLRELKVVARDGGMVPLASVMEVRQAMGPAIMMRYNLYPAAPIVGIPNPFEGGSVLIDRVATAAREELPENYSYEWTEVFLLQIAAGNTAGLLLGLGVILVFLVLAALYESWAQPLAVILVVPLCLLAAVVGLLLSFLPIDILAQVGLVVLVGLACKNAILIVEFARQLHAEGHDARSAAITASRLRLRPILMTSLAFILGVVPLVIARGAGAELRWSLGVTVFAGMIGVTLFGIFLTPVFYEKLTGLSDRWQARGPEPEATRP	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	99.81	gnl|BL_ORD_ID|138|hsp_num:0	153		
k141_528199_2 # 511 # 2247 # 1 # ID=507028_2;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.564	k141_528199_2	511	2247	+	Strict	500	536.2	APH(3')-IIa	100.0	3002644	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGCTGATGGTGCACGACCACGCATTAATGGACTGGATTGGGGCCAACTCCTACCGTACCTCGCATTACCCTTACGCTGAAGAGATGCTCGACTGGGCAGATGAACATGGCATCGTGGTGATTGATGAAACTGCTGCTGTCGGCTTTAACCTCTCTTTAGGCATTGGTTTCGAAGCGGGCAACAAGCCGAAAGAACTGTACAGCGAAGAGGCAGTCAACGGGGAAACTCAGCAAGCGCACTTACAGGCGATTAAAGAGCTGATAGCGCGTGACAAAAACCACCCAAGCGTGGTGATGTGGAGTATTGCCAACGAACCGGATACCCGTCCGCAAGGTGCACGGGAATATTTCGCGCCACTGGCGGAAGCAACGCGTAAACTCGACCCGACGCGTCCGATCACCTGCGTCAATGTAATGTTCTGCGACGCTCACACCGATACCATCAGCGATCTCTTTGATGTGCTGTGCCTGAACCGTTATTACGGATGGTATGTCCAAAGCGGCGATTTGGAAACGGCAGAGAAGGTACTGGAAAAAGAACTTCTGGCCTGGCAGGAGAAACTGCATCAGCCGATTATCATCACCGAATACGGCGTGGATACGTTAGCCGGGCTGCACTCAATGTACACCGACATGTGGAGTGAAGAGTATCAGTGTGCATGGCTGGATATGTATCACCGCGTCTTTGATCGCGTCAGCGCCGTCGTCGGTGAACAGGTATGGAATTTCGCCGATTTTGCGACCTCGCAAGGCATATTGCGCGTTGGCGGTAACAAGAAAGGGATCTTCACTCGCGACCGCAAACCGAAGTCGGCGGCTTTTCTGCTGCAAAAACGCTGGACTGGCATGAACTTCGGTGAAAAACCGCAGCAGGGAGGCAAACATGAATCAACAACTCTCCTGGCGCACCATCGTCGGCTACAGCCTCGGGAATTGCTACCGAGCTCGAGCTTGGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGA	MLMVHDHALMDWIGANSYRTSHYPYAEEMLDWADEHGIVVIDETAAVGFNLSLGIGFEAGNKPKELYSEEAVNGETQQAHLQAIKELIARDKNHPSVVMWSIANEPDTRPQGAREYFAPLAEATRKLDPTRPITCVNVMFCDAHTDTISDLFDVLCLNRYYGWYVQSGDLETAEKVLEKELLAWQEKLHQPIIITEYGVDTLAGLHSMYTDMWSEEYQCAWLDMYHRVFDRVSAVVGEQVWNFADFATSQGILRVGGNKKGIFTRDRKPKSAAFLLQKRWTGMNFGEKPQQGGKHESTTLLAHHRRLQPRELLPSSSLDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF	MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF	218.94	gnl|BL_ORD_ID|1959|hsp_num:0	2114		
k141_538540_2 # 402 # 1223 # -1 # ID=517349_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.513	k141_538540_2	402	1223	-	Perfect	500	559.3	linG	100.0	3002879	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGCTTCAACTGAAAATGATAGAACTCTTCAAGGAAGGTTGTCATGAGGATGCACGAATAATCGCGGCATTGATGTTCGGCTCATTTGCTATCGGAGAGGGTGACGAGTTCTCTGATATCGAATTCGCAGTGTTCATCCAGGATGACCATTTTGAAAATTTCGATCAGCGCTCGTGGCTTAATGCCGTAAGTCCGGTTGCTGCTTACTTTCCGGACGACTTCGGCCACCACACCGCACTTTTTGAAAACGGCATTCGCGGTGAATTCCATTTCATGCGAAAATCGGACATACCGGTCATTTCCACTTGGCAAGGCTATGGGTGGTTTCCCTCGCTTGAGGCGGCTGTTTTGTTGGACCGATCAGGAGAGTTGTCAAGGTACGCAAGCGCTCTCGTGGGCGGTCCCCCGATACGTGAAGGCGCGCCGCTGGTGGAAGGGCTTGTGTTGAACCTCATCAGCCTGATGCTCTTTGGGGCCAATCTTTTAAATCGGGGAGAGTACGCTCGCGCCTGGGCTTTGCTCAGCAAAGCACATGAAAACCTACTCAAGCTGGTTCGACTCCACGAAGGGGCAACAGACCACTGGCCGACACCTTCACGCGCGCTCGAAAAGGATATCTCGGAGGACTCGTATAATCGCTATCTGGCATGCACAAGCAGTGCAGAACCAAGAGCACTATGTGCAGCCTATCATCAAACGTGGACGTGGAGTCTCGAATTGTTCAAGAGCGTGACAGAACCTCTGAATATCGAGCTTCCGAGAACTGTAATTGCGCAGGCAAAAAGGTTGCTCAATGAGTCTGCGACGCCGCACAACAAGTAA	MLQLKMIELFKEGCHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQDDHFENFDQRSWLNAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEAAVLLDRSGELSRYASALVGGPPIREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDISEDSYNRYLACTSSAEPRALCAAYHQTWTWSLELFKSVTEPLNIELPRTVIAQAKRLLNESATPHNK	MLQLKMIELFKEGCHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQDDHFENFDQRSWLNAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEAAVLLDRSGELSRYASALVGGPPIREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDISEDSYNRYLACTSSAEPRALCAAYHQTWTWSLELFKSVTEPLNIELPRTVIAQAKRLLNESATPHNK	100.00	gnl|BL_ORD_ID|1771|hsp_num:0	1873		
k141_562926_2 # 616 # 1302 # -1 # ID=541681_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.665	k141_562926_2	616	1302	-	Strict	420	428.7	mtrA	95.18	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGGGCCATGAGGCAACGGATCCTGGTCGTCGATGACGACCCCTCGCTGGCGGAGATGCTGACGATCGTCCTGCGGAACGAGGGTTTCGACACCGCGGTGATCGCCGACGGCACCCAGGCGCTGACCGCGGTGCGCGAACTGCGCCCCGACCTGGTGTTACTGGACCTGATGCTGCCCGGCATGAACGGCATCGACGTCTGCCGGGTGCTGCGCGCCGATTCCGGGGTCCCGATCGTGATGCTGACCGCCAAGACCGACACCGTCGACGTGGTGCTCGGGCTGGAGTCCGGCGCCGACGACTATGTGATGAAGCCGTTTAAACCCAAGGAGCTGGTGGCCCGCGTGCGGGCCCGGCTGCGCCGCAACGAGGACGAGCCCGCCGAGATGCTGTCCATCGGCGACATCGAGATCGACGTGCCCGCCCACAAGGTGACCCGCGACGGTGAGCAGATCTCGCTCACTCCCCTGGAGTTCGACCTGCTGGTGGCGTTGGCGCGCAAACCGCGGCAGGTGTTTACTCGAGATGTGCTGCTCGAGCAGGTGTGGGGTTACCGGCATCCCGCCGACACCCGGCTGGTGAACGTGCATGTCCAGCGACTGCGCGCCAAGGTTGAGAAGGACCCGGAGAACCCGCAGGTGGTGCTCACCGTTCGAGGAGTGGGATACAAGGCCGGACCTCCGTGA	MGAMRQRILVVDDDPSLAEMLTIVLRNEGFDTAVIADGTQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYVMKPFKPKELVARVRARLRRNEDEPAEMLSIGDIEIDVPAHKVTRDGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPQVVLTVRGVGYKAGPP	MDTMRQRILVVDDDASLAEMLTIVLRGEGFDTAVIGDGTQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYIMKPFKPKELVARVRARLRRNDDEPAEMLSIADVEIDVPAHKVTRNGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPTVVLTVRGVGYKAGPP	100.00	gnl|BL_ORD_ID|1467|hsp_num:0	1559		
k141_588464_3 # 1190 # 1981 # 1 # ID=567155_3;partial=01;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.616	k141_588464_3	1190	1981	+	Strict	500	504.2	sul2	100.0	3000412	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTATCTGGCGCCAGACGCAGCCATTGCGCAGGCGCGTAAGCTGATGGCCGAGGGGGCAGATGTGATCGACCTCGGTCCGGCATCCAGCAATCCCGACGCCGCGCCTGTTTCGTCCGACACAGAAATCGCGCGTATCGCGCCGGTGCTGGACGCGCTCAAGGCAGATGGCATTCCCGTCTCGCTCGACAGTTATCAACCCGCGACGCAAGCCTATGCCTTGTCGCGTGGTGTGGCCTATCTCAATGATATTCGCGGTTTTCCAGACGCTGCGTTCTATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTG	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAAL	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	97.42	gnl|BL_ORD_ID|895|hsp_num:0	952		
k141_598443_5 # 2951 # 6145 # -1 # ID=577112_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.488	k141_598443_5	2951	6145	-	Strict	750	803.9	adeF	42.76	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGCTATCAATCTCTGATTTCTTTATCCGTAGACCTGTTTTTGCCACGGTCTGTTCTTTGGTAATCACCTTGATGGGGGCAACCTGTATATTTTTACTGCCCGTTGCCCAATATCCCGAAATTACGCCGCCAAAAGTCACAGTAACCACAAACTACGTGGGCGCAAATGCCGAGGTGGTGGAGTCTACGGTCACGAATATTTTAGAAAGAGAACTCAACGGCATTGAGGGAGTGCGCTACATCACCTCCACTAGTTCCAACGATGGTACAAGTATTGTCAATCTTGTATTTGATCTAGACAAAGACAAAGACATTGCGGCGGTGGATGTGCAGAACCGCGTATCTACGGTGCAGGCGCAGTTGCCTGGTCCTGTGCAGCAAACGGGCGTGAGAGTTAGTAAAGAGTCTTCAGGATTTTTGTTTGCGATCGGGGTTTATGCCGAAAATGGGCAGTATGACGATCTGTATTTGAGTAATTATGCCGATCTATATATTGTCGATGCGATCAAAAAGGTTGATGGCGTTGGCAATGTGATCATTTTCGGTGAACGCAAGTATGCGATGCGGGTTTGGCTCGATCCCAATCGCTTGGCAGCCAGAGGCTTAACTTCGCAGGATGTGGTGGCGGCAATCCAGCAACAGAATTTGCAGGTGGGTGTGGGACAGATTGGACAGCAGCCGAATTTGCCCAATCAGCAATATCAGTTATCAGTTTCTGCTAAGGGGCGGCTGCAAAGCGCCGATGAGTTTGCCCAAATTGTGATTAAAACTAATGGCGATGGCTCTTTAATCAAGCTTGGTGATGTGGGGCGCGTGGAATTGGGAGCGGAAAATTATGGCTCTTCCCTGCGGTTTAATGGCACTCGTGGCATTGGGCTAGGGGTGTCGCAGTTACCTGATGCTAATGCCCTTGAAGTAGCCCATGCTGTGAAAAAGATCTTGGAGGGGCTAAGACCTAATTTTCCACCAGGGCTAGATTATAAAATCGCCTTTGATACGACTAGCTTCATTGAGGCGGGGACGGAGGAGGTGATCATTTCGCTGTTAATTGCGATCGCCTTGGTAATCGTAATTATTTATTTGTTCCTGCAAAATTGGCGCTCCACCTTGATCCCTGCGATCGCCATTCCTGTGGCTTTGGTCGGTACTTTTATCTTCATCAAGCTCTTAGATTTTAATATCAATACCCTCACCCTATTCGGCTTGACCCTGGCTACAGGGTTAGTGGTTGATGATGCGATCGTGGTGGTGGAGGATATCACCCGCCGTATTCAAGAAAACCATGAGCCACCGATACAAGCAGCGATCGCGGCAATGAATGAGTTGCAGGGCGCGGTCATTGCCAGTTCCTTAGTGCTAGTGGCGGTATTTGTGCCTGTGGCATTTTTTCCTGGGACAACGGGGCAGTTATACAAGCAATTTGCGCTGACGATCGCCTTCTCGATCACAGTTTCCACATTTAACGCGATCACTCTATCCCCCACCCTTGCCGCGATTTTGCTCAAGCAGGAAGCTCCAAAAAGTAATTGGTTTTTCGATCGACTCAACGGTGTAATTGATCGCACCCGCCAAGGCTATCAATGGAGCGTCACCAAACTGACTGGGTTCAAAGGGATAGTGATGGTGCTGTTTATTGCCTCTCTATTTTTGACCTATTGGGTCTATACGATTGTGCCAAGGGGATTTCTGCCCCAAGAGGATCAGGGCTATTTCATCACGATCGTGCAAGCGCCCGAAGGCGTATCTCTTAATTACACTGAGAAGGTGCTGGAAAACATCGAAGGGATCATGCGCCGCAAGGATGAAAATGGTCAACCTGCCTATCCTGAAATTGCCAATATTTTTGCAGTGGGCGGCTTTAGTTTTAGCGGCAATACGCCAAATAATGGCATTGTCTTTGCCACCCTCAAACCCTGGAAAGAGCGATCGCGATCGGCGGATGCCATCATCGGCGGGTTTGCCCCTGCCCCCTTTGGTTTATTACCCGAACTGATTTCGATCAAAGAAGCATTTGTAGTTCCCTTCCCGCCCCCTGCGATTCAGGGCTTGAGCAACTATGGCGGTTTTGAGTTTCAATTGCAGGACAAAGCCAATCAAGGCTTCCCCGCCATTGAACAGACGATGGGAGCGCTTTTAGGAGCCGCCAGTACCTATCCTGACCCCAGCCGTCCCAGCTTGGCAGGATTGCGCCCCAACTTTAATGGCAATACGCCGCAGCTAACCGTAGAGGTCGATCGCGTCAAAGTAAACGCTTTGCAGGTCTCTTTGCAGGATATTTACGCCACCTTGCAAACCCTGCTCGGTTCCCAATATGTCAATGATTTCAATGCTTTTGGGCGCACCTATCGCGTCTATGTACAGGCAGATGCTCAATTCCGCGCCAACCCCGATGACATCAATAAGATCTATGTGCGATCGCGCAATGGCACAATGATCCCCCTTAGCAATCTGGTCAAGGTGCAGCAAACCGTTGGACCTTCGATCATTAACCATTACAATCTCCTGCGCTCGGTGCAGATCACAGGCAACACCGCCCCAGGGGTCAGTTCGGGACAGGCGATCGATATCATTACTAAAGTTGCTAATCAAGTGCTGCCGAAAACCTTTGATTATGAATGGTCTGGGCTATCCCTAGAAGAAATTGGCTCTGGCAATAGTGCCATTTTTATCTTTGGCTTAGGCGTAGTCTTTGTATTCCTGGTACTCGCCGCCCAATATGAAAACTACATCGATCCCGCGATTATTATGCTCACCGTGCCTTTAGCGGTGTTAGGCGCATTATTGGCAGTGATGTTTCGCAGTTTATCTAGCCCTAACTTTTCTAACGATGTCTATACTCAGATTGGACTCGTGATGCTCGTGGGCATGGCGAGTAAAAATGCAATTTTGATTGTGGAGTTTGCCAACCAGTTACGGGAGCAGGGCTTGAGTATTACTAAGGCTGCGATCGAGGCTTCACAGCAGCGCCTACGCCCAATTTTGATGACTGCCTTCTCCACGATTATCGGCATCTTCCCTCTCGTAATTGCCACTGGGGCAGGAGCCGCCGCCCGTCAGTCCATCGGCACGGCGGTGATGGGGGGGATGTGTGTGGCAACCTTGTTAAGTTTATTTATTGTGCCAATTCTCTATATTGTGGTTAAAAACATTGAAGAAAGAATGAAAGTCGGGCTACATCGTCCAAATCCATAA	MLLSISDFFIRRPVFATVCSLVITLMGATCIFLLPVAQYPEITPPKVTVTTNYVGANAEVVESTVTNILERELNGIEGVRYITSTSSNDGTSIVNLVFDLDKDKDIAAVDVQNRVSTVQAQLPGPVQQTGVRVSKESSGFLFAIGVYAENGQYDDLYLSNYADLYIVDAIKKVDGVGNVIIFGERKYAMRVWLDPNRLAARGLTSQDVVAAIQQQNLQVGVGQIGQQPNLPNQQYQLSVSAKGRLQSADEFAQIVIKTNGDGSLIKLGDVGRVELGAENYGSSLRFNGTRGIGLGVSQLPDANALEVAHAVKKILEGLRPNFPPGLDYKIAFDTTSFIEAGTEEVIISLLIAIALVIVIIYLFLQNWRSTLIPAIAIPVALVGTFIFIKLLDFNINTLTLFGLTLATGLVVDDAIVVVEDITRRIQENHEPPIQAAIAAMNELQGAVIASSLVLVAVFVPVAFFPGTTGQLYKQFALTIAFSITVSTFNAITLSPTLAAILLKQEAPKSNWFFDRLNGVIDRTRQGYQWSVTKLTGFKGIVMVLFIASLFLTYWVYTIVPRGFLPQEDQGYFITIVQAPEGVSLNYTEKVLENIEGIMRRKDENGQPAYPEIANIFAVGGFSFSGNTPNNGIVFATLKPWKERSRSADAIIGGFAPAPFGLLPELISIKEAFVVPFPPPAIQGLSNYGGFEFQLQDKANQGFPAIEQTMGALLGAASTYPDPSRPSLAGLRPNFNGNTPQLTVEVDRVKVNALQVSLQDIYATLQTLLGSQYVNDFNAFGRTYRVYVQADAQFRANPDDINKIYVRSRNGTMIPLSNLVKVQQTVGPSIINHYNLLRSVQITGNTAPGVSSGQAIDIITKVANQVLPKTFDYEWSGLSLEEIGSGNSAIFIFGLGVVFVFLVLAAQYENYIDPAIIMLTVPLAVLGALLAVMFRSLSSPNFSNDVYTQIGLVMLVGMASKNAILIVEFANQLREQGLSITKAAIEASQQRLRPILMTAFSTIIGIFPLVIATGAGAAARQSIGTAVMGGMCVATLLSLFIVPILYIVVKNIEERMKVGLHRPNP	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	100.47	gnl|BL_ORD_ID|138|hsp_num:0	153		
k141_608241_4 # 5158 # 5844 # -1 # ID=586895_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.643	k141_608241_4	5158	5844	-	Strict	420	422.5	mtrA	93.86	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTCGCCATGAGGCAAAGGATCTTGGTCGTCGATGACGACCCCTCGCTGTCGGAGATGCTCACCATCGTCCTGCGCAACGAAGGTTTCGAGACGGCGGTCATCGCGGACGGCTCGCAGGCGCTGACCGCGGTCCGGGAACTGCGGCCGGATCTGGTACTGCTGGACCTGATGCTGCCCGGCATGAACGGCATCGACGTATGCCGGGTGCTGCGTGCCGACTCCGGTGTGCCGATCGTCATGCTGACCGCCAAGACCGACACCGTCGACGTGGTGCTCGGTCTGGAGTCCGGCGCCGACGACTATGTCATGAAGCCGTTCAAACCCAAGGAACTGGTGGCCCGGGTCCGGGCCCGGTTGCGGCGCAACGAGGACGAGCCGGCCGAGATGCTGTCCATCGGCGATATCGAGATTGACGTTCCCGCGCACAAGGTGACCCGCGAGGGTGAGCAGATCTCCCTGACGCCGCTGGAGTTCGACCTGCTGGTGGCATTGGCGCGTAAACCGCGACAGGTGTTTACTCGAGATGTACTGCTCGAACAGGTGTGGGGGTACCGTCATCCCGCCGACACTCGTTTGGTGAATGTCCACGTGCAGCGGTTGCGGGCGAAGGTCGAGAAGGACCCGGAGAACCCGCAGGTCGTGCTGACCGTTCGTGGCGTGGGTTACAAGGCCGGCCCGCCGTGA	MVAMRQRILVVDDDPSLSEMLTIVLRNEGFETAVIADGSQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYVMKPFKPKELVARVRARLRRNEDEPAEMLSIGDIEIDVPAHKVTREGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPQVVLTVRGVGYKAGPP	MDTMRQRILVVDDDASLAEMLTIVLRGEGFDTAVIGDGTQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYIMKPFKPKELVARVRARLRRNDDEPAEMLSIADVEIDVPAHKVTRNGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPTVVLTVRGVGYKAGPP	100.00	gnl|BL_ORD_ID|1467|hsp_num:0	1559		
k141_624652_1 # 2 # 337 # 1 # ID=603272_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.545	k141_624652_1 	2	337	+	Strict	500	159.1	sul4	100.0	3004361	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ACCCTCCCCCTAAAATGGGGAGGGAACATCTCCCTCTCCCGGTGGGAGAGGGCTGGGGAGAGGGTGAAAAAAATTTTCAAGGAACTGCTATTGATGTCAACCACACTAACCAGCTTCAAATGGGGTGAACGCACCTACATCATGGGCATCCTCAACGTCACTCCAGACAGCTTTTCTGGAGATGGCGTTATGGTTGAAGAAGATGTCATCGCCAAAGCGGTAGCCCAGGCCAAACAATTTGTAGCCGACGGCGCAGACATCATCGACATTGGCGGCGAGAGTACCCGCCCTGGCAGCTCACCTATAAGCGCAGAGGAAGAACTGGCGCGGGTGCTG	TLPLKWGGNISLSRWERAGERVKKIFKELLLMSTTLTSFKWGERTYIMGILNVTPDSFSGDGVMVEEDVIAKAVAQAKQFVADGADIIDIGGESTRPGSSPISAEEELARVL	MSTTLTSFKWGERTYIMGILNVTPDSFSGDGVMVEEDVIAKAVAQAKQFVADGADIIDIGGESTRPGSSPISAEEELARVLPVVQAVRQAVDVVISIDSYRASVAEAALAAGASWLNDVWGLRMDPDMAGLAAQAGCPIVLMHNRSKPKNIAQEKKLGGRFIGVKYDDLITDVKRELQESIDIALKAGVKESQIILDPGIGFGKTVEQSLQLLDQINQFKTMGFPILIGPSRKSFIGYTLDLPPDQRIEGTAATVAIGIDRGADVVRVHDVKAIVRVARMTDAIVRR	39.02	gnl|BL_ORD_ID|2555|hsp_num:0	2875	True	loose hit with at least 95 percent identity pushed strict
k141_631267_3 # 1183 # 1257 # 1 # ID=609877_3;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.667	k141_631267_3 	1183	1257	+	Strict	200	54.3	RbpA	100.0	3000245	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	RbpA bacterial RNA polymerase-binding protein	ATGGCTGATCGTGTGCTCAGGGGCAGCCGGCTCGGAGCTGTGAGCTACGAGACCGACCGCAACCACGACCTCGCG	MADRVLRGSRLGAVSYETDRNHDLA	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGDVPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKAKRRGTGS	21.93	gnl|BL_ORD_ID|1341|hsp_num:0	1425	True	loose hit with at least 95 percent identity pushed strict
k141_677065_1 # 3 # 107 # 1 # ID=655569_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.590	k141_677065_1 	3	107	+	Strict	500	75.9	APH(3')-IIa	100.0	3002644	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGA	ELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF	MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF	12.88	gnl|BL_ORD_ID|1959|hsp_num:0	2114	True	loose hit with at least 95 percent identity pushed strict
k141_681812_2 # 507 # 3731 # -1 # ID=660307_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.679	k141_681812_2	507	3731	-	Strict	750	877.1	adeF	47.53	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCGCGGGCTTCTTCATCGAGCGGCCGATCTTCGCGTCGGTGATCTCGATCGTGCTGGTGCTGTGCGGCGGGGTCGCCGCCGTCACCCTGCCGACCACCCAGTATCCCGAGATCACGCCGCCCACCATCGAGGTCTCGACGGTCTACCCCGGGGCGAATGCCGAGCTGGTCCGCGACACGATCGCCGCACCGATCGAGCAGCAGGTGAGCGGTGTGGAAAACGCCCTCTCGCTCAGCTCCCAATGCACCAACGACGGCCGCTACCGCCTCACCGTCACCTTCGCCCCGGGCACCGATCTCAACATGGCCCAGGTGCTCACCCAGGTGCGGGTCACGCTGGCGATGCCCAGCCTGCCCGACCTCGTGCAGCGGGAGGGGGTGGCAGTGCTGAAGAAGTCACCGGCGGCGATGATGATCGTCAACTTCACCGCCGCCAAGGATGCCGGCGGCAAGCCCCTCTACGACGAGATCTTCCTCTCCAACTACGCCACGATCCAGATTCGCGACGAGCTGCTGCGGGTCGAGGGCATCGGCGACATCGACTTCATCGGGCAGCGGGACTACAGCATGCGGGTCTGGCTCGATCCGCAGCGGATGGCCGCGGTCGGCCTCTCGGCGGGCGACGTCCGCGCGGCGCTCGAGAACCAGAACTATCAGATCACGGCCGGCAGCGTCGGCCAGCAGCCGGCCCCGCAGGGGCAGGCCTTCCAGATTCCGCTCTCCGCCGTGGGCCGGCTGGTGACGGTGGAGGAGTTTGGCAATGTGATCGTCAAGGAGACGCCAGCGGAAGACGGCGACGTGGCGGCCGTGATCGTGCGGCTGCGGGACGTCGCCCGGGTCGAACTCGGGGCCCAGTTTTACGACCAGATCTGCCGGCTCGACGGCGAGCCGAGCGTGGGCATGAACATCTACCAGCTGCCCGGCTCCAACGCGATCGCCGCCGCCGAGGCCGTGCGGGCAAAACTGGCGGCCCTCGGGGAACGGTTTCCGAAGGGGCTCGAAGCGCGGGTGGTCTACGACACGACGCCCTTCATCGAGGAGTCGAAGGCGGAGGTGCTCAAGACCCTCCGCGATGCGACGATCCTCGTGGCGTTGGTGGTGCTGCTTTTCTTGCAGAACTGGCGGGCCACCCTGATCCCCCTGATCGCGGTGCCGGTGGCGATCGTGGGCACCTTCGCCTTCATGGCCGCACTGGGCTTCAGCCTCAACAACCTCTCGCTGTTCGGGCTCGTGCTGGCGATCGGCATCGTGGTGGACGATGCGATCGTCGTGGTCGAGAACGTGGAACGCTGGATCGAGCAGGGGCTCTCCCCGCGGGACGCGTCGTTCAGGGCGATGCAGGAGGTCACCGGGCCGGTGATCGGCGTGGCGCTGGTGCTCTGCGCCGTGTTCGTCCCCTGCAGCTTCATCGCCGGGATCGTCGGCCAGTTCTTCCGGCAGTTCGCCCTGACGATCGCGGTCTCGACGCTGCTCTCGGCGGTCAACTCCCTCACGCTCTCACCGGCGCTGGCCGCCATCCTGTTGCGTCCGCACGGGGCGGCCCCGGACCCCGTCGACCGCATCCTGCGATTGACCTGCGGCTGGATCTTCCGCGGCTTCAACGCCGGGTTTGCCATCCTGACTCGCGGCTACGCCTGGGCGGTCAGAGGGGCGCTCCAGCTGGCCTGGCTGATCCTCCTGGCGTTTGCCGGCCTGCTTGTGCTCACGTGGGTGTTGTTCACGCAGACGCCGGTCGGCTTCATCCCGGAGCAGGACAAGGGCTACCTGATCGCCGACGTCGTGCTCCCGGAGGGGGCGAGTGTGCAGCGGACGGCGGAGGTAATGGCGGCGCTCGAGCGACGGGCGCTCGAGGAGCCGGGGGTGGCCCATGCCGTGTCGGTGGCCGGGCGGTCGGTGGTACTCGGGGCCAACTCCCCGAACTGGGCCGCGATGTACGTGATGCTCGACGACTTCGCCGAGCGACGGGACGCCGCTTTGTCGTCCGAACGAATCGCGGCCCGGCTTCGCCACGACTGGCAGGCCACGGTGGACGACGCCCGCGTAGAGGTCTTCGGGCCGCCGCCGGTGGACGGCCTCGGCACGGTGGCGGGCTTCAAGCTCGCCCTGGAGGACCGGGGTGACTACGGCGCCGCCCAACTCGAGGAGGCGACCGCGGCATTGATCGCCGAGTGCCGGGAGGATCAACGCCTCACGGGCCTGTTCACCAACTACTCGGCCAGTGCGCCGTGGCTGTTTCTCGACATCGACCGCGACAAGGCGACGGCGGTGGGCGTACGGCTGACGGATCTGTTTGAGACGCTGCAGGTGCAGCTGGGCTCTTACTACATCAACAACTTCAACCGCTTCGGGCGGTCGTGGCAGGTCAACGTGCAGGCCGACGCCCGTCACCGTGGCGACATCCGCCGGGCCATCGACGAGCTCATGGTGCCGGGGCTCGATGGACGCTCGGTGCCCTTGGCGACGCTGGTGCAGGTGAAGGATCGCGTCGGTCCTTCGCTCTTGATGCGATACAACCTCTATCCGACGGCGGCCGTCTACGGCGAGCCCGCCGCGGGGACGGGGAGCACCTCGGCGCTGGCGATCGTACAGGAGCACTTCGACCGGCTTCAGGCGGAGGCGACGATTCCGCCGCTGTTTGCCGCCGAGTGGACGGAGATGGCCTTCATGCAGATCCGCTCCGGAGCCACGGCCACCTTCCTGTTCGTGCTCGGTGTGGTGCTCGTGTTTCTCGTGCTCGCGGCGCTCTACGAGAGCTGGGCCCTACCGCTGGCAGTGATTCTCGTGGTGCCGATGTGCCTGCTCTCGGCGGTCGTGGGCATCCGTCAGGCGGGCATGGAGATCACGATCTTCACCCAGATCGGCTTCGTGGTGCTCGTGGGGCTGGCCTGCAAGAACGCGATTCTGATCGTCGAGTTTGCCCGGCAGCTCACTCACGAGGGGAAACCGCTCCTGGACGCTACCGTGGAGGCCAGCCGGCTGCGACTGCGGCCGATCCTGATGACGTCGCTGGCCTTCATCCTCGGCGTGCTGCCGCTGGTGGTCGCGGAAGGCGCGGGCGCCGAGATGCGTCGGACGCTTGGCCTGGCCGTGTTCAGCGGGATGCTGGGCGTGACGCTGTTCGGCATCTTTGTCACCCCGGTGTTCTTCTACACGCTGCTGCGGGGCGACGGCAGACCCCGGGGCTCCTTGCCGGCGGAAGCAGCTGCGGTTGGAGACCCGTGA	MIAGFFIERPIFASVISIVLVLCGGVAAVTLPTTQYPEITPPTIEVSTVYPGANAELVRDTIAAPIEQQVSGVENALSLSSQCTNDGRYRLTVTFAPGTDLNMAQVLTQVRVTLAMPSLPDLVQREGVAVLKKSPAAMMIVNFTAAKDAGGKPLYDEIFLSNYATIQIRDELLRVEGIGDIDFIGQRDYSMRVWLDPQRMAAVGLSAGDVRAALENQNYQITAGSVGQQPAPQGQAFQIPLSAVGRLVTVEEFGNVIVKETPAEDGDVAAVIVRLRDVARVELGAQFYDQICRLDGEPSVGMNIYQLPGSNAIAAAEAVRAKLAALGERFPKGLEARVVYDTTPFIEESKAEVLKTLRDATILVALVVLLFLQNWRATLIPLIAVPVAIVGTFAFMAALGFSLNNLSLFGLVLAIGIVVDDAIVVVENVERWIEQGLSPRDASFRAMQEVTGPVIGVALVLCAVFVPCSFIAGIVGQFFRQFALTIAVSTLLSAVNSLTLSPALAAILLRPHGAAPDPVDRILRLTCGWIFRGFNAGFAILTRGYAWAVRGALQLAWLILLAFAGLLVLTWVLFTQTPVGFIPEQDKGYLIADVVLPEGASVQRTAEVMAALERRALEEPGVAHAVSVAGRSVVLGANSPNWAAMYVMLDDFAERRDAALSSERIAARLRHDWQATVDDARVEVFGPPPVDGLGTVAGFKLALEDRGDYGAAQLEEATAALIAECREDQRLTGLFTNYSASAPWLFLDIDRDKATAVGVRLTDLFETLQVQLGSYYINNFNRFGRSWQVNVQADARHRGDIRRAIDELMVPGLDGRSVPLATLVQVKDRVGPSLLMRYNLYPTAAVYGEPAAGTGSTSALAIVQEHFDRLQAEATIPPLFAAEWTEMAFMQIRSGATATFLFVLGVVLVFLVLAALYESWALPLAVILVVPMCLLSAVVGIRQAGMEITIFTQIGFVVLVGLACKNAILIVEFARQLTHEGKPLLDATVEASRLRLRPILMTSLAFILGVLPLVVAEGAGAEMRRTLGLAVFSGMLGVTLFGIFVTPVFFYTLLRGDGRPRGSLPAEAAAVGDP	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	101.42	gnl|BL_ORD_ID|138|hsp_num:0	153		
k141_741318_3 # 1852 # 2184 # 1 # ID=719709_3;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.508	k141_741318_3	1852	2184	+	Strict	180	209.5	qacL	99.09	3005098	protein homolog model	n/a	n/a	disinfecting agents and intercalating dyes	antibiotic efflux	small multidrug resistance (SMR) antibiotic efflux pump	GTGAAGAACTGGATATTTCTGGCTGTTGCAATCTTTGGCGAGGTCATCGCAACTTCCGCACTGAAGTCTAGCCATGGATTCACTAGGTTAGTTCCTTCCGTTGTAGTTGTGGCTGGCTACGGGCTTGCGTTCTATTTCTTGTCTCTCGCGCTCAAGTCCATTCCGGTCGGTATTGCTTACGCTGTATGGGCTGGGCTTGGCATCGTGCTTGTGGCAGCTATTGCTTGGATTTTCCATGGCCAAAAACTAGACTTCTGGGCGTTCATTGGCATGGGACTTATCGTCAGTGGCGTCGCCGTTCTAAACCTGCTATCCAAGGTCAGCGCACATTGA	MKNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYAVWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH	MKNWIFMAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYAVWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH	100.00	gnl|BL_ORD_ID|2888|hsp_num:0	3830		
k141_741318_4 # 2270 # 2455 # 1 # ID=719709_4;partial=01;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.468	k141_741318_4 	2270	2455	+	Strict	500	124.0	OXA-3	100.0	3001398	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCAATCCGAATCTTCGCAATACTTTTCTCCACTTTTGTTTTTGGCACGTTCGCGCATGCACAAGAAGGCATGCGCGAACGTTCTGACTGGCGGAAGTTTTTCAGCGAATTTCAAGCCAAAGGCACGATAGTTGTGGCAGACGAACGCCAAACAGATCGTGTCATATTGGTTTTTGATCAGGTG	MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFDQV	MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFDQVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNSTVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYHNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRIGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR	22.55	gnl|BL_ORD_ID|773|hsp_num:0	816	True	loose hit with at least 95 percent identity pushed strict
k141_759617_1 # 2 # 289 # 1 # ID=737977_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.514	k141_759617_1 	2	289	+	Strict	500	191.8	TEM-215	100.0	3001392	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	TTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAA	LTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	33.22	gnl|BL_ORD_ID|1888|hsp_num:0	1999	True	loose hit with at least 95 percent identity pushed strict
k141_768818_1 # 2 # 391 # 1 # ID=747159_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.654	k141_768818_1 	2	391	+	Strict	420	253.8	mtrA	95.35	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GACGACTACGTGATGAAGCCGTTCAAACCCAAGGAGCTGGTGGCCCGCGTGCGGGCCCGGCTGCGCCGCAATGAGGACGAGCCGGCCGAGATGCTGTCCATCGGCGACATCGAGATCGACGTGCCCGCCCACAAGGTGACCCGCGACGGGGAGCAGATCTCGCTCACGCCCCTGGAGTTCGACCTTCTGGTGGCATTGGCGCGTAAACCGCGGCAGGTGTTTACTCGAGATGTGCTGCTTGAACAGGTGTGGGGGTACCGGCACCCGGCCGACACCCGGCTGGTCAACGTGCACGTCCAGCGACTCCGCGCCAAGGTCGAGAAGGACCCGGAGAACCCCCAGGTGGTTCTCACCGTTCGAGGAGTGGGATACAAGGCCGGACCTCCGTGA	DDYVMKPFKPKELVARVRARLRRNEDEPAEMLSIGDIEIDVPAHKVTRDGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPQVVLTVRGVGYKAGPP	MDTMRQRILVVDDDASLAEMLTIVLRGEGFDTAVIGDGTQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYIMKPFKPKELVARVRARLRRNDDEPAEMLSIADVEIDVPAHKVTRNGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPTVVLTVRGVGYKAGPP	56.58	gnl|BL_ORD_ID|1467|hsp_num:0	1559	True	loose hit with at least 95 percent identity pushed strict
k141_783799_1 # 100 # 1326 # -1 # ID=762109_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.335	k141_783799_1	100	1326	-	Strict	400	631.3	EreD	75.0	3004608	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGAAAAATATAAAATCTGTTGCTTCCGATTTTATTTCGGAGAGCAATGTATCAGTAAGACAAACGCTATCTCAATTCAGAGAACATTTTGATTCATCGACAATTCTTGCGATAGGAGAAAACTCACATTTCATAAAAGAATTTTTCACTTTAAGGCATCAGATTATTGAGTTTCTGATAACCGAATGTAATTTCGATACCATAGCTTTTGAATTCGGCTTTTCCGAGGGATTAAAAATTGATAAGTGGATAAAATCAAAACTTCCATTGGAGGATTTGGACAGTTTGTTGTCTCATTTTTATTATCCGACAGAGTTCAAAGCTACGTTACTTTGGCTTCGTAATTACAATCAGAAAAACAAAAATCAAATTACGTTTTTAGGTCTTGACGTGCCTAAAAACGGAGGCTCTTATTTTCCAACATTTCATATTGTAGCTGATTATTTGCAGAAGAATTCAATTGCTTCGTCTGATATTTTAAAGAAGATTTCAGACCTTGTTGAAAAACTTGATTTTCTTTCAACATCTCAATTAGCGTTGAATTTATCGAATATTGATAATCTAGAACACAATGAATTAAAGGCATTATTATTAAGCGTTTACATTAGATTGATTAGCCTTCAGCCGAAGTTGGAAAGTTTAACGTTTCAGACCGTTCTTCATCAGGTAAAAGGGCTGATGTACACGAACTACAATGCTAATGCAATGGCTGATTTTATTAACGAAAAAGGACTTGAAGGAGATATGGGAGCAAAAGACCAATTTATGGCAGAGAGTATTGATTGGTTTTTGAAAAACTCACTTGGCAAAAAAATCATATTGGTTGCCCACAATGCCCATATCCAAAAAACTCCTGTTGATTTTGACGGATTCATCAGTTGTTATCCTATGGGACAGCGACTTGCTATGTCTTATGGAAGTGGATATAAGGCGTTTGCTATAACTAATTTTGCAGGGGAAACATCTGCATTGTATCCTGACAATGAGTATAAATTTGGGTTTAAAGTTGATAAATTTCCGCTTGGTTTTCCCGAGTCGGATTCTATTGAATTTTTTATGAGAAAATCGGGCTTGGAAGAGGGTTTGTTAATAATGAACGAAAGCTTGGAATTGAAAAATCACAAAACGATTCGATTTGATTCAATGTATTTAAATACAGAAATTCAAAAGGCTTTTGACGGTATTTTTCTAATAGAAAAATCAACTGTTTCGGAAGTAGTTAATTGA	MKNIKSVASDFISESNVSVRQTLSQFREHFDSSTILAIGENSHFIKEFFTLRHQIIEFLITECNFDTIAFEFGFSEGLKIDKWIKSKLPLEDLDSLLSHFYYPTEFKATLLWLRNYNQKNKNQITFLGLDVPKNGGSYFPTFHIVADYLQKNSIASSDILKKISDLVEKLDFLSTSQLALNLSNIDNLEHNELKALLLSVYIRLISLQPKLESLTFQTVLHQVKGLMYTNYNANAMADFINEKGLEGDMGAKDQFMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQRLAMSYGSGYKAFAITNFAGETSALYPDNEYKFGFKVDKFPLGFPESDSIEFFMRKSGLEEGLLIMNESLELKNHKTIRFDSMYLNTEIQKAFDGIFLIEKSTVSEVVN	MKNIKPLTFPFNSENNTSIKQSLFRFREYFDSSTIVGLGENSHFIKEFFTFRHQVIEFLVTECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDNNNQITFLGVDIPKNGGSYFPNFRIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLALNLSLFDEAEHNELKALLLKVYIRLVTLQPKLESLEFQSILHQVKGLIYMNYNADAMESFITEKGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQRLSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDSPESDSVEFFMQELSGKECCLIINKSKELKNCSKIRFDSIYLKTEIVDSFDGIFLIEKSTVSEIVD	100.00	gnl|BL_ORD_ID|1230|hsp_num:0	3305		
k141_815064_2 # 227 # 904 # -1 # ID=793313_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.659	k141_815064_2	227	904	-	Strict	420	427.6	mtrA	95.11	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGGCAACGGATCCTGGTCGTCGACGACGACCCCTCGCTGGCCGAGATGCTGACCATCGTGCTTCGCAACGAGGGTTTCGAGACGGCGGTCGTCGGTGACGGCTCGCAGGCGCTGACCGCGGTCCGCGAACTGCGGCCCGATCTGGTGCTGCTCGACCTGATGCTGCCCGGCATGAACGGAATCGACGTATGCCGGGTGCTGCGGGCCGATTCCGGCGTCCCGATTGTGATGCTGACCGCCAAGACCGACACCGTCGACGTGGTGCTGGGCCTGGAGTCCGGTGCCGACGACTACGTCATGAAGCCGTTCAAGCCCAAAGAACTGGTGGCCCGGGTGCGGGCCCGGTTGCGGCGCAACGATGACGAGCCCGCCGAGATGCTGTCCATCGGCGACATCGAGATCGACGTGCCGGCGCACAAGGTCACCCGCGACGGCGAGCAGATCTCGTTGACCCCGCTAGAGTTCGACCTGCTGGTAGCGTTGGCGCGCAAGCCCCGGCAGGTGTTTACTCGGGACGTGTTGCTCGAGCAGGTGTGGGGATACCGGCATCCGGCCGATACCCGTCTGGTCAACGTGCACGTCCAGCGGTTGCGGGCCAAGGTCGAGAGGGATCCGGAGAACCCGCAGGTGGTGTTGACCGTTCGAGGAGTGGGTTACAAGGCCGGACCGCCATGA	MRQRILVVDDDPSLAEMLTIVLRNEGFETAVVGDGSQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYVMKPFKPKELVARVRARLRRNDDEPAEMLSIGDIEIDVPAHKVTRDGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVERDPENPQVVLTVRGVGYKAGPP	MDTMRQRILVVDDDASLAEMLTIVLRGEGFDTAVIGDGTQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYIMKPFKPKELVARVRARLRRNDDEPAEMLSIADVEIDVPAHKVTRNGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPTVVLTVRGVGYKAGPP	98.68	gnl|BL_ORD_ID|1467|hsp_num:0	1559		
k141_826473_2 # 993 # 4130 # -1 # ID=804696_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.427	k141_826473_2	993	4130	-	Strict	750	802.0	adeF	43.77	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCAGATTTTTTATTACACGGCCGATTTTTGCATCAGTGTTGTCTATCATTATCGTGTTATCTGGATTGGCTGCTGCATTCAAGTTGCCAATTGCGCAATATCCACAAATTGCACCACCAACAGTTACTATTACGGCCGTTTATCCTGGAGCAAGTGCTGATACGCTTTCAAAGACTGTGGCTGCACCAATTGAAGAGCAATTGAGTGGTGTTGATAACCTCCTTTATTTTAATTCCAGTGCTGACTCTAGCGGCACCTTAGTTATTACAGCTACTTTCGAAGTGGGTACTAATGTTGATCAAGCAACGTTTAATGTAAGTAACCGAGTCAATATTGCTACGCCTCGCCTGCCTGATGAGGTTCGTCGTAACGGGCTAATTGTTCAAAAGAAATCAAACGATATTTTATTGGTCGTGATGTTGACTTCTAAAGATAAGAATCATGATCGATTATTTTTAAGCAATTATGCAACGCTTAATGTGATGGATGAGCTTAAGCGAGTCAAGGGTGTAGGTGATGCTGTTATTTTTGGCGGTCAGGATTATTCGATGCGTGTTTGGTTGCGTCCAGATCGTATGGCGCAACTAGGCATTACTACCAGTGACATTGCATCTGCTATTAGCGCACAAAACAATCAATATGCAGCTGGCAAAATCGGTGCCGAGCCTGCCCCATCGTCGCAGCAATTGGTCTATACCGTCACAGCCAAAGGCCGGTTAATAGATCCTGCTCAATTTGCCAATATCATTATTAGAGCCGACGGTCCGAATGGTGTTTTATATCTTCAGGATGTCGCTCGCATTGAGCTCGGCGCACAAAACTACAATGTGGCATCAACCCTTGATGGAACTCCAGGTGTTGCGATACCTATTTTCTTGCAAACCGGCGCTAATGCTTTAGATACTGCTAAAAATATCAAGCTTAAGATGAATGAGCTTAAAGAAACCTTTCCTAAGGGGATGGAGTTTACGATTCCCTATGATACGAGTGACTTCGTTAAAGCAACTATCAATGAAGTCTTTCATACATTTGGTGAAGCCTTGCTACTTGTTGTGCTTGTGGTCTTTTTGTTTCTGCAAAGCTGGCGTGCGACTTTAATTCCTATTATCGCAGTTCCTATTTCTTTGATTGGTACTTTTGCTGGCCTTTACTTGTTTGGCTTCTCAATTAATCTCTTGACTTTATTTGCCATGATTTTAGCGATTGGGATCGTGGTGGATGATGCGATTGTTGTCTTAGAGAATACTGAACGACTAATGTCAGAAGAAGGGTTAGCTCCTTTACCTGCAGCCATCAAATCAATTCGTCAGGTATCTGCGGCGGTGGTAGCTATTGTTTTAGTACTATGTGCCGTATTCGTCCCCGTAGCCTTTCAAGGTGGTATCGCTGGTGAGTTATACCGTCAATTTGCCGTCACTGTGGCAATTGCTGTCGTGATTTCCGGTGTCGTTGCTTTAACACTAACACCCGCACTTTGTGCCATGATCCTAAAGAAAGCTGATGGGAAAAATGCTTTCTTCACTAAATTTAATCAGTTATTTAGCCAATTAACACACTTTTATACGTATGTCGTTAACTTGACGCTCAAGCATAAAGGAATTAGTGGATCTATATTTGTTGCAGTAATTATCCTAGTCGCAATATTGTTTAGAGCTGTTCCAGCTAGTTTTGTACCGGCGGAAGATCAGGGTTATGTTGTTACAATTGTCATCATGCCTGATGGCGCAACCTTGAGTCGTACCTCTAAAACAACCGAAAATATACGATCAGCCATAGCCCATGATTCAGCTGTGGCGCATGAGTTTGCTGTTAATGGCTTTGAATTATTGACGGGTGCAAATAAAACTAATGCTGCCACCATGTTTGTAAGACTTAAAGATTGGAATGAGCGAGAGGCATCCGCAACAGATATCGTTGATAAGTTGTTTGGAATTGGAATGAGCCAAAATGATGGCTTGGCAATTGCAGTAAATCCACCAGCAATTCGTGGATTAGGGTCTGCTGGTGGTTTTGAGGTTTATGTGCAAAGTCAGCGTGACACAGATCCTATTAAGTTAGCAGCGGTGATGAATGACTTTATTGATGCGATGCGAGCTGAGCCAACTTTAACTGGGCTGAACTCATTCTTTCGACCGACTGTTCCTCAGTTAATGATAGAAGTGGATGAGGCAAAGGCCATTTCTCAAGGGGTTCGTATTGCGGATATTTATGCAACTTTACAAAGTACGATGGGTGCTTTTTATGTAAATGATTTTAACCGTAACGGCCGTACTTACCGAGTTCAATTGCAAGCTGAATCTGAATTTAGAATGCAACCGGACGATTTAGGTAAAGTTTATGTGCGCAGTCAGCCTACATTAGCCAATCCAAGTGGCAATATGATTCCACTTTCAGCGCTAAGTAAGGTGAGTAACATCGTTGGCGCCGAGCAACTAGAACGCTATAACGGATTATTGTCAGCAAAGGTGTTTGGAAGTGGTGGTGCTGGGGTTAGTTCTGGGGATGCTATTGAAACTGTAGAGCGTATTGCAAAAAATACCTTGCCTGAGGGATATAAGATTGCATGGACCGGGCAGGCATACCAAGAAAAACGAACAGGTTCTGCAGCGATGTATGCTTTTGGTTTCGCCATTATTATGGTGTTTTTGATATTGGCAGCGCAATTTGAAACATGGGCTTTGCCACTTGCAGTGATTATGGCTGTGCCATTTGCGCTCGCCGGTGCTTTGTTGGCTGTTTTGTTACGTGGCATGCCTAATGACATTTATTTCCAAATAGGATTGATTACCTTAATTGGATTGGCGGCTAAGAATGCGATTTTGATTGTAGAGTTTGCAGAACAAAAAATGGAGGAGGGCATGCCAGTTGCGCAAGCAGCATTAGAAGCCGCAAGATTACGTTTTAGACCTATTGTGATGACATCAATGGCCTTTGTTCTAGGGATTGTTCCTTTGGTGTTTGCAACAGGTGCAGGAGCTGCCGCTCGCCGCTCCATGGGCACTGGTGTGTTTGGTGGAATGATTTTAGCGACTTTTGTAGCAACGATATTTATTCCATTATTTTTTACTTGGCTTTCCGGCAAGCATGTTCGTCATCACGGACATCTTGATGGACTGCCAGAGGAAGATAAATAA	MTRFFITRPIFASVLSIIIVLSGLAAAFKLPIAQYPQIAPPTVTITAVYPGASADTLSKTVAAPIEEQLSGVDNLLYFNSSADSSGTLVITATFEVGTNVDQATFNVSNRVNIATPRLPDEVRRNGLIVQKKSNDILLVVMLTSKDKNHDRLFLSNYATLNVMDELKRVKGVGDAVIFGGQDYSMRVWLRPDRMAQLGITTSDIASAISAQNNQYAAGKIGAEPAPSSQQLVYTVTAKGRLIDPAQFANIIIRADGPNGVLYLQDVARIELGAQNYNVASTLDGTPGVAIPIFLQTGANALDTAKNIKLKMNELKETFPKGMEFTIPYDTSDFVKATINEVFHTFGEALLLVVLVVFLFLQSWRATLIPIIAVPISLIGTFAGLYLFGFSINLLTLFAMILAIGIVVDDAIVVLENTERLMSEEGLAPLPAAIKSIRQVSAAVVAIVLVLCAVFVPVAFQGGIAGELYRQFAVTVAIAVVISGVVALTLTPALCAMILKKADGKNAFFTKFNQLFSQLTHFYTYVVNLTLKHKGISGSIFVAVIILVAILFRAVPASFVPAEDQGYVVTIVIMPDGATLSRTSKTTENIRSAIAHDSAVAHEFAVNGFELLTGANKTNAATMFVRLKDWNEREASATDIVDKLFGIGMSQNDGLAIAVNPPAIRGLGSAGGFEVYVQSQRDTDPIKLAAVMNDFIDAMRAEPTLTGLNSFFRPTVPQLMIEVDEAKAISQGVRIADIYATLQSTMGAFYVNDFNRNGRTYRVQLQAESEFRMQPDDLGKVYVRSQPTLANPSGNMIPLSALSKVSNIVGAEQLERYNGLLSAKVFGSGGAGVSSGDAIETVERIAKNTLPEGYKIAWTGQAYQEKRTGSAAMYAFGFAIIMVFLILAAQFETWALPLAVIMAVPFALAGALLAVLLRGMPNDIYFQIGLITLIGLAAKNAILIVEFAEQKMEEGMPVAQAALEAARLRFRPIVMTSMAFVLGIVPLVFATGAGAAARRSMGTGVFGGMILATFVATIFIPLFFTWLSGKHVRHHGHLDGLPEEDK	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.68	gnl|BL_ORD_ID|138|hsp_num:0	153		
k141_856867_1 # 109 # 681 # -1 # ID=835040_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.522	k141_856867_1 	109	681	-	Strict	550	394.0	lnuF	100.0	3002839	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	GGCATTCGCGGTGAATTCCATTTCATGCGAAAATCGGACATACCGGTCATTTCCACTTGGCAAGGCTACGGGTGGTTTCCCTCGCTTGAGGAGGCTGTTTTGTTGGACCGATCAGGAGAGTTGTCAAGGTACGCGAGTGCTCTCGTGGGCAGTCCCCCGAAACGTGAAGGCGCGCCGCTGGTGGAAGGACTTGTATTGAACCTCATCAGCCTGATGCTCTTTGGGGCAAATCTTTTAAATCGGGGAGAGTATGCTCGCGCCTGGGCTTTGCTCAGCAAAGCACATGAAAACTTACTCAAGTTGGTTCGCCTCCATGAAGGGGCAACAGACCACTGGCCGACACCTTCACGCGCGCTCGAAAAGGATGTCTCGGAGGACTCGTATAATCGCTACCTGGCATGCACAGGCAGCGCGGAACCAAAAGCACTATGTGTAGCCTATCATGAAACGTGGAAGTGGAGTCTCGAATTGTTCAGGAGTGTGGCTGGACCTCTGAATATCGAGCTTCCGAGAATTGTAATTGCGCAGACAAAAAGGTTGCTAAATGAATCTGCGACGCCGCACAACAAGTAA	GIRGEFHFMRKSDIPVISTWQGYGWFPSLEEAVLLDRSGELSRYASALVGSPPKREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDVSEDSYNRYLACTGSAEPKALCVAYHETWKWSLELFRSVAGPLNIELPRIVIAQTKRLLNESATPHNK	MLQQKMIERFKEACHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQNNHFENFDQRSWLNAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEEAVLLDRSGELSRYASALVGSPPKREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDVSEDSYNRYLACTGSAEPKALCVAYHETWKWSLELFRSVAGPLNIELPRIVIAQTKRLLNESATPHNK	69.60	gnl|BL_ORD_ID|1404|hsp_num:0	1491	True	loose hit with at least 95 percent identity pushed strict
k141_864994_1 # 285 # 428 # -1 # ID=843155_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.389	k141_864994_1 	285	428	-	Strict	500	97.1	mphG	100.0	3003742	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	CAAGGTGGAGAAGTATGGGATAAACTGTTTGAACAAGCAGTTGAACGAGCTGCTGCCGCACCTCTAGCTTATGGATATTTTGCTTTAGAAACACAAGATGAAATTCATCTTAGTTCTGCAAAATTACAGTTAGGTGTTGAGTAG	QGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGVE	MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPRRTTLGEQIANEKRILQLVSKYLSVQVPDWRIANEKLVAYPLLDGKPALTYDAETYEVTWNMSKENDLYIPSLAKALIELHSIPTEEVLRNNLKILTPEQVRNEISERLILVKSELGINAELELRYQKWLDNDALWPNFTKFIHGDLYAGHTLTHHNGEVCGIIDWSTAQVSDIAQDFSGHVTVFGEESLKNLIAAYEKQGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGVE	15.99	gnl|BL_ORD_ID|2089|hsp_num:0	2259	True	loose hit with at least 95 percent identity pushed strict
k141_867617_1 # 1 # 378 # 1 # ID=845775_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.489	k141_867617_1 	1	378	+	Strict	500	242.3	OXA-21	100.0	3001416	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	AATTCTACTGTCTGGATTTATGAGCTATTTGCAAAAGAGATCGGTGAAGACAAGGCTCGACGCTATTTGAAGCAAATCGACTATGGCAACGCCGATCCTTCGACAAGTAATGGCGATTACTGGATAGATGGCAATCTTGCTATCGCGGCACAAGAACAGATTGCATTTCTCAGGAAGCTCTATCATAACGAGTTGCCCTTTCGGGTAGAACATCAGCGCTTGGTCAAGGACCTCATGATTGTGGAAGCCGGTCGCAACTGGATACTGCGCGCAAAGACGGGCTGGGAAGGCCGCATGGGTTGGTGGGTAGGATGGGTTGAGTGGCCGACTGGCCTTGATGATATGCCATTCATTCTGATGATTAGAGACGAGACATGA	NSTVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYHNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGLDDMPFILMIRDET	MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFDQVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNSTVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYHNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR	45.45	gnl|BL_ORD_ID|198|hsp_num:0	213	True	loose hit with at least 95 percent identity pushed strict
k141_867617_4 # 1760 # 1984 # 1 # ID=845775_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.573	k141_867617_4 	1760	1984	+	Strict	500	97.8	OXA-3	100.0	3001398	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGGGCCAAATTCATGCGGCCGCTCAACGAACGCGGTTCGGCACCCCAGGGCCTGGGCGGCATCGAGATCATCTTTGTGGGCCCCGTATTCTTCGCACTGAATATTGATACGCCAAACAGGATGGATGACCTTTTCAAAAGGGAGGCAATAGTGCGGGCAATCCTTCGCTCTATCGAAGCGTTGCCGCCCAACCCGGCAGTCAACTCGGACGCAGCGCGATAA	MGAKFMRPLNERGSAPQGLGGIEIIFVGPVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR	MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFDQVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNSTVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYHNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRIGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR	26.91	gnl|BL_ORD_ID|773|hsp_num:0	816	True	loose hit with at least 95 percent identity pushed strict
k141_867617_5 # 2021 # 2809 # 1 # ID=845775_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=3-4bp;gc_cont=0.583	k141_867617_5	2021	2809	+	Perfect	450	527.7	aadA5	100.0	3002605	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGGTGAATTTTTCCCTGCACAAGTTTTCAAGCAGCTGTCCCACGCTCGCGCGGTGATCGAGCGCCATCTGGCTGCGACACTGGACACAATCCACCTGTTCGGATCTGCGATCGATGGAGGGCTGAAGCCGGACAGCGACATAGACTTGCTCGTGACCGTCAGCGCCGCACCTAACGATTCGCTCCGGCAGGCGCTAATGCTCGATTTGCTGAAAGTCTCATCACCGCCAGGCGATGGCGGAACATGGCGACCGCTGGAGCTAACTGTTGTCGCTCGAAGCGAAGTAGTGCCTTGGCGCTATCCGGCGCGGCGTGAGCTTCAGTTCGGTGAGTGGCTCCGCCACGACATCCTTTCCGGAACGTTCGAGCCTGCCGTTCTGGATCACGATCTTGCGATTTTGCTGACCAAGGCGAGGCAACACAGCCTTGCGCTTCTAGGCCCATCCGCAGCCACGTTTTTCGAGCCGGTGCCGAAGGAGCATTTCTCCAAGGCGCTTTTCGACACTATTGCCCAGTGGAATGCAGAGTCGGATTGGAAGGGTGACGAGCGGAACGTCGTTCTTGCTCTTGCTCGCATTTGGTACAGCGCTTCAACTGGTCTCATTGCTCCTAAGGACGTTGCTGCCGCATGGGTATCGGAGCGTTTGCCTGCCGAGCATCGGCCCCTCATCTGCAAGGCACGCGCGGCGTACCTGGGTAGCGAGGACGACGACCTAGCAATGCGCGTCGAAGAGACGGCCGCGTTCGTTCGATATGCCAAAGCAACGATTGAGAGAATCTTGCGTTGA	MGEFFPAQVFKQLSHARAVIERHLAATLDTIHLFGSAIDGGLKPDSDIDLLVTVSAAPNDSLRQALMLDLLKVSSPPGDGGTWRPLELTVVARSEVVPWRYPARRELQFGEWLRHDILSGTFEPAVLDHDLAILLTKARQHSLALLGPSAATFFEPVPKEHFSKALFDTIAQWNAESDWKGDERNVVLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPLICKARAAYLGSEDDDLAMRVEETAAFVRYAKATIERILR	MGEFFPAQVFKQLSHARAVIERHLAATLDTIHLFGSAIDGGLKPDSDIDLLVTVSAAPNDSLRQALMLDLLKVSSPPGDGGTWRPLELTVVARSEVVPWRYPARRELQFGEWLRHDILSGTFEPAVLDHDLAILLTKARQHSLALLGPSAATFFEPVPKEHFSKALFDTIAQWNAESDWKGDERNVVLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPLICKARAAYLGSEDDDLAMRVEETAAFVRYAKATIERILR	100.00	gnl|BL_ORD_ID|1336|hsp_num:0	1420		
k141_387043_4 # 2905 # 3276 # -1 # ID=366184_4;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.556	k141_387043_4 	2905	3276	-	Strict	200	211.8	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin	86.18	3003395	protein variant model	K88R	n/a	aminoglycoside antibiotic	antibiotic target alteration	antibiotic-resistant rpsL	GTGCCCACAATTCAGCAGTTGATCCGTCAGGGTCGAAGCAGCAAAGTAACAAAATCGAAGACTCCCGCGTTGAAGGGTTCACCTCAGCGACGCGGTGTGTGCACACGCGTGTTCACGACCACACCAAAGAAGCCAAACTCGGCTCTGCGAAAAGTTGCTCGTGTTCGTTTGACCAGTGGCGTTGAAGTCACCGCATACATCCCAGGTGAGGGACACAACTTGCAAGAGCACAGCATCGTGTTAGTGCGTGGTGGTCGTGTTCGTGACCTTCCAGGTGTTCGTTACAAGATCATCCGTGGCGCTCTCGACGCCGCAGGTGTAAAGAATCGCAAGCAGGCGCGCAGCCGTTACGGCGCAAAGCGCGAGAAATAA	MPTIQQLIRQGRSSKVTKSKTPALKGSPQRRGVCTRVFTTTPKKPNSALRKVARVRLTSGVEVTAYIPGEGHNLQEHSIVLVRGGRVRDLPGVRYKIIRGALDAAGVKNRKQARSRYGAKREK	MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG	99.19	gnl|BL_ORD_ID|2004|hsp_num:0	1197		
k141_399640_3 # 7017 # 7385 # 1 # ID=378764_3;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.547	k141_399640_3 	7017	7385	+	Strict	200	204.9	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin	83.61	3003395	protein variant model	K88R	n/a	aminoglycoside antibiotic	antibiotic target alteration	antibiotic-resistant rpsL	GTGCCCACAATTCAGCAGCTGATTCGACAAGGTCGCAGCACCAAGTCGACAAAAACCAAGACCCCTGCGCTCAAGGGTTCACCACAGCGACGTGGAGTATGCACACGCGTATTCACCACAACGCCAAAAAAGCCAAACTCGGCGCTCCGCAAAGTAGCCCGTGTTCGCTTGACGAGCGGCGTGGAAATCACCGCGTACATTCCAGGAGAAGGCCACAACTTGCAAGAGCACTCCATCGTGTTGGTTCGCGGTGGTCGTGTGCGTGACTTGCCAGGTGTTCGTTACAAAGTTATTCGTGGCGCACTTGATGCTGCCGGAGTAAAAGATCGCAAGCAAGCCCGTAGCCGTTACGGCGCAAAGAAGAAATAG	MPTIQQLIRQGRSTKSTKTKTPALKGSPQRRGVCTRVFTTTPKKPNSALRKVARVRLTSGVEITAYIPGEGHNLQEHSIVLVRGGRVRDLPGVRYKVIRGALDAAGVKDRKQARSRYGAKKK	MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG	98.39	gnl|BL_ORD_ID|2004|hsp_num:0	1197		
k141_425855_8 # 12745 # 13119 # 1 # ID=404918_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.645	k141_425855_8 	12745	13119	+	Strict	200	222.2	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin	89.43	3003395	protein variant model	K88R	n/a	aminoglycoside antibiotic	antibiotic target alteration	antibiotic-resistant rpsL	GTGCCAACAATCCAGCAGCTAGTCCGCAAGGGCCGGCAGGACAAGGTGTCCAAGACCAAGGCTCCAGCGCTCAAGGGCAGCCCCCAGCGCCGTGGAGTCTGCACGCGTGTGTACACCACCACCCCCAAGAAGCCGAACTCCGCGCTTCGCAAGGTGGCCCGCGTCCGTCTGACCTCCCAGATCGAGATCACCGCGTACATCCCCGGTGTCGGCCACAACCTCCAAGAGCATTCGATCGTCCTCGTCCGCGGCGGTCGCGTCCGTGACCTCCCCGGCGTTCGCTACAAGGTCATCCGCGGTGCCCTCGATACCCAGGGCGTCAAGAACCGCAAGCAGGCACGTTCTCGTTACGGCGCGAAGAAGGAGAAGGCCTAA	MPTIQQLVRKGRQDKVSKTKAPALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVRLTSQIEITAYIPGVGHNLQEHSIVLVRGGRVRDLPGVRYKVIRGALDTQGVKNRKQARSRYGAKKEKA	MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG	100.00	gnl|BL_ORD_ID|2004|hsp_num:0	1197		
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_651189	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_533001	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_917869	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_610123	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_534805	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_884746	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_864696	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_482432	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_338505	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_68102	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_842754	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_238081	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_70465	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_73982	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_216991	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_248571	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_208831	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2482_4108 | model_type_id: 40295 | pass_bit_score: 2500 | SNP: U14G,A474C,C856U,A858C,A859G,A1123G,A1123C,G1125A | Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin | QUERY: k141_225451	k141_651189	1	333	+	Strict	2500	536.649	Chlamydomonas reinhardtii 16S rRNA (rrnS) mutation conferring resistance to streptomycin	95.8	3003978	rRNA gene variant model	A474C	n/a	aminoglycoside antibiotic	antibiotic target alteration	16s rRNA with mutation conferring resistance to aminoglycoside antibiotics	GGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGAGGAATTTTTCGCAATGGGCGCAAGCCTGACGAAGCAATGCCGCGTGCAGGAAGAAGGCCTGTGGGTCGTAAACTGCTTTTCTCAGAGAAGAAGTTCTGACGGTATCTGAGGAATAAGCTCCGGCTAACTCTGTGCCAGCCGCCGCGGTAATACAGAGGGAGCAAGCGTTATCCGGAATGATTGGGCGTAAAGCGTTTGTAGGTGGTTCGTAAAGTCTAATGTCAAATACCAGGGCTCAACCCTGGACCGGCATTGGAGCACTCACGAACTTGA			22.52	gnl|BL_ORD_ID|629749|hsp_num:0	2482	True	loose hit with at least 95 percent identity pushed strict
2811_4157 | model_type_id: 40295 | pass_bit_score: 5700 | SNP: A2272C,A2274G,A2274U | Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin | QUERY: k141_388674	k141_388674	964	3	-	Strict	5700	1531.99	Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin	95.43	3004164	rRNA gene variant model	A2274G	n/a	macrolide antibiotic	antibiotic target alteration	23S rRNA with mutation conferring resistance to macrolide antibiotics	TAAACGGCGGTGGTAACTATAACCATCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCTGCACGAATGGCGTAACGACTTCTCAACTGTCTCAACCATAGACTCGGCGAAATTGCACTACGAGTAAAGATGCTCGTTACGCGCGGCAGGACGAAAAGACCCCGGGACCTTCACTATAGCTTGGTATTGATGTTCGATACGGTTTGTGTAGGATAGGTGGGAGACTATGAAGCGATA-ACGCCAGTTATTGTGGAGTCGTTGTTGAAATACCACTCTGATCGTATTGGACCTCTAACTTCGAACCGTATATCCGGTTCAGGGACAGTGCCTGGTGGGTAGTTTAACTGGGGCGGTTGCCTCCTAAAAAGTAACGGAGGCGCCCAAAGGTTCCCTCAACCTGGACGGCAATCAGGTGTTGAGTGCAAGTGCACAAGGGAGCTTGACTGCGAGACATACATGTCGAGCAGGGACGAAAGTCGGGACTAGTGATCCGGCACCTCTGAGTGGAAGGGGTGTCGCTCAACGGATAAAAGGTACCCCGGGGATAACAGGCTGATCTTCCCCAAGAGTCCATATCGACGGGATGGTTTGGCACCTCGATGTCGGCTCGTCGCATCCTGGGGCTGGAGCAGGTCCCAAGGGTTGGGCTGTTCGCCCATTAAAGCGGCACGCGAGCTGGGTTTAGAACGTCGTGAGACAGTTCGGTCTCTATCCGCCGCGCGCGTCAGAAGCTTGAGGAAAGCTGTCCCTAGTACGAGAGGACCGGGACGGACGAACCTCTGGTCCACCAGTTGTCCCACCAGGGGCACCGCTGGATAGCCACGTTCGGACAGGATAACCGCTGAAAGCATCTAAGCGGGAAACCTTCTCCAAGACCAGGCTTCTCACCCATTAAGTGGGATAAGGCCCCCCGCAGACCACGGGATCGATAGACCAGACCTGTAACCGCAGCAATG			-30.88	gnl|BL_ORD_ID|367813|hsp_num:0	2811	True	loose hit with at least 95 percent identity pushed strict
2811_4157 | model_type_id: 40295 | pass_bit_score: 5700 | SNP: A2272C,A2274G,A2274U | Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin | QUERY: k141_96748	k141_388674	964	3	-	Strict	5700	1531.99	Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin	95.43	3004164	rRNA gene variant model	A2274G	n/a	macrolide antibiotic	antibiotic target alteration	23S rRNA with mutation conferring resistance to macrolide antibiotics	TAAACGGCGGTGGTAACTATAACCATCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCTGCACGAATGGCGTAACGACTTCTCAACTGTCTCAACCATAGACTCGGCGAAATTGCACTACGAGTAAAGATGCTCGTTACGCGCGGCAGGACGAAAAGACCCCGGGACCTTCACTATAGCTTGGTATTGATGTTCGATACGGTTTGTGTAGGATAGGTGGGAGACTATGAAGCGATA-ACGCCAGTTATTGTGGAGTCGTTGTTGAAATACCACTCTGATCGTATTGGACCTCTAACTTCGAACCGTATATCCGGTTCAGGGACAGTGCCTGGTGGGTAGTTTAACTGGGGCGGTTGCCTCCTAAAAAGTAACGGAGGCGCCCAAAGGTTCCCTCAACCTGGACGGCAATCAGGTGTTGAGTGCAAGTGCACAAGGGAGCTTGACTGCGAGACATACATGTCGAGCAGGGACGAAAGTCGGGACTAGTGATCCGGCACCTCTGAGTGGAAGGGGTGTCGCTCAACGGATAAAAGGTACCCCGGGGATAACAGGCTGATCTTCCCCAAGAGTCCATATCGACGGGATGGTTTGGCACCTCGATGTCGGCTCGTCGCATCCTGGGGCTGGAGCAGGTCCCAAGGGTTGGGCTGTTCGCCCATTAAAGCGGCACGCGAGCTGGGTTTAGAACGTCGTGAGACAGTTCGGTCTCTATCCGCCGCGCGCGTCAGAAGCTTGAGGAAAGCTGTCCCTAGTACGAGAGGACCGGGACGGACGAACCTCTGGTCCACCAGTTGTCCCACCAGGGGCACCGCTGGATAGCCACGTTCGGACAGGATAACCGCTGAAAGCATCTAAGCGGGAAACCTTCTCCAAGACCAGGCTTCTCACCCATTAAGTGGGATAAGGCCCCCCGCAGACCACGGGATCGATAGACCAGACCTGTAACCGCAGCAATG			-30.88	gnl|BL_ORD_ID|367813|hsp_num:0	2811	True	loose hit with at least 95 percent identity pushed strict
2811_4157 | model_type_id: 40295 | pass_bit_score: 5700 | SNP: A2272C,A2274G,A2274U | Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin | QUERY: k141_139660	k141_388674	964	3	-	Strict	5700	1531.99	Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin	95.43	3004164	rRNA gene variant model	A2274G	n/a	macrolide antibiotic	antibiotic target alteration	23S rRNA with mutation conferring resistance to macrolide antibiotics	TAAACGGCGGTGGTAACTATAACCATCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCTGCACGAATGGCGTAACGACTTCTCAACTGTCTCAACCATAGACTCGGCGAAATTGCACTACGAGTAAAGATGCTCGTTACGCGCGGCAGGACGAAAAGACCCCGGGACCTTCACTATAGCTTGGTATTGATGTTCGATACGGTTTGTGTAGGATAGGTGGGAGACTATGAAGCGATA-ACGCCAGTTATTGTGGAGTCGTTGTTGAAATACCACTCTGATCGTATTGGACCTCTAACTTCGAACCGTATATCCGGTTCAGGGACAGTGCCTGGTGGGTAGTTTAACTGGGGCGGTTGCCTCCTAAAAAGTAACGGAGGCGCCCAAAGGTTCCCTCAACCTGGACGGCAATCAGGTGTTGAGTGCAAGTGCACAAGGGAGCTTGACTGCGAGACATACATGTCGAGCAGGGACGAAAGTCGGGACTAGTGATCCGGCACCTCTGAGTGGAAGGGGTGTCGCTCAACGGATAAAAGGTACCCCGGGGATAACAGGCTGATCTTCCCCAAGAGTCCATATCGACGGGATGGTTTGGCACCTCGATGTCGGCTCGTCGCATCCTGGGGCTGGAGCAGGTCCCAAGGGTTGGGCTGTTCGCCCATTAAAGCGGCACGCGAGCTGGGTTTAGAACGTCGTGAGACAGTTCGGTCTCTATCCGCCGCGCGCGTCAGAAGCTTGAGGAAAGCTGTCCCTAGTACGAGAGGACCGGGACGGACGAACCTCTGGTCCACCAGTTGTCCCACCAGGGGCACCGCTGGATAGCCACGTTCGGACAGGATAACCGCTGAAAGCATCTAAGCGGGAAACCTTCTCCAAGACCAGGCTTCTCACCCATTAAGTGGGATAAGGCCCCCCGCAGACCACGGGATCGATAGACCAGACCTGTAACCGCAGCAATG			-30.88	gnl|BL_ORD_ID|367813|hsp_num:0	2811	True	loose hit with at least 95 percent identity pushed strict
2811_4157 | model_type_id: 40295 | pass_bit_score: 5700 | SNP: A2272C,A2274G,A2274U | Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin | QUERY: k141_919532	k141_388674	964	3	-	Strict	5700	1531.99	Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin	95.43	3004164	rRNA gene variant model	A2274G	n/a	macrolide antibiotic	antibiotic target alteration	23S rRNA with mutation conferring resistance to macrolide antibiotics	TAAACGGCGGTGGTAACTATAACCATCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCTGCACGAATGGCGTAACGACTTCTCAACTGTCTCAACCATAGACTCGGCGAAATTGCACTACGAGTAAAGATGCTCGTTACGCGCGGCAGGACGAAAAGACCCCGGGACCTTCACTATAGCTTGGTATTGATGTTCGATACGGTTTGTGTAGGATAGGTGGGAGACTATGAAGCGATA-ACGCCAGTTATTGTGGAGTCGTTGTTGAAATACCACTCTGATCGTATTGGACCTCTAACTTCGAACCGTATATCCGGTTCAGGGACAGTGCCTGGTGGGTAGTTTAACTGGGGCGGTTGCCTCCTAAAAAGTAACGGAGGCGCCCAAAGGTTCCCTCAACCTGGACGGCAATCAGGTGTTGAGTGCAAGTGCACAAGGGAGCTTGACTGCGAGACATACATGTCGAGCAGGGACGAAAGTCGGGACTAGTGATCCGGCACCTCTGAGTGGAAGGGGTGTCGCTCAACGGATAAAAGGTACCCCGGGGATAACAGGCTGATCTTCCCCAAGAGTCCATATCGACGGGATGGTTTGGCACCTCGATGTCGGCTCGTCGCATCCTGGGGCTGGAGCAGGTCCCAAGGGTTGGGCTGTTCGCCCATTAAAGCGGCACGCGAGCTGGGTTTAGAACGTCGTGAGACAGTTCGGTCTCTATCCGCCGCGCGCGTCAGAAGCTTGAGGAAAGCTGTCCCTAGTACGAGAGGACCGGGACGGACGAACCTCTGGTCCACCAGTTGTCCCACCAGGGGCACCGCTGGATAGCCACGTTCGGACAGGATAACCGCTGAAAGCATCTAAGCGGGAAACCTTCTCCAAGACCAGGCTTCTCACCCATTAAGTGGGATAAGGCCCCCCGCAGACCACGGGATCGATAGACCAGACCTGTAACCGCAGCAATG			-30.88	gnl|BL_ORD_ID|367813|hsp_num:0	2811	True	loose hit with at least 95 percent identity pushed strict
2811_4157 | model_type_id: 40295 | pass_bit_score: 5700 | SNP: A2272C,A2274G,A2274U | Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin | QUERY: k141_850537	k141_388674	964	3	-	Strict	5700	1531.99	Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin	95.43	3004164	rRNA gene variant model	A2274G	n/a	macrolide antibiotic	antibiotic target alteration	23S rRNA with mutation conferring resistance to macrolide antibiotics	TAAACGGCGGTGGTAACTATAACCATCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCTGCACGAATGGCGTAACGACTTCTCAACTGTCTCAACCATAGACTCGGCGAAATTGCACTACGAGTAAAGATGCTCGTTACGCGCGGCAGGACGAAAAGACCCCGGGACCTTCACTATAGCTTGGTATTGATGTTCGATACGGTTTGTGTAGGATAGGTGGGAGACTATGAAGCGATA-ACGCCAGTTATTGTGGAGTCGTTGTTGAAATACCACTCTGATCGTATTGGACCTCTAACTTCGAACCGTATATCCGGTTCAGGGACAGTGCCTGGTGGGTAGTTTAACTGGGGCGGTTGCCTCCTAAAAAGTAACGGAGGCGCCCAAAGGTTCCCTCAACCTGGACGGCAATCAGGTGTTGAGTGCAAGTGCACAAGGGAGCTTGACTGCGAGACATACATGTCGAGCAGGGACGAAAGTCGGGACTAGTGATCCGGCACCTCTGAGTGGAAGGGGTGTCGCTCAACGGATAAAAGGTACCCCGGGGATAACAGGCTGATCTTCCCCAAGAGTCCATATCGACGGGATGGTTTGGCACCTCGATGTCGGCTCGTCGCATCCTGGGGCTGGAGCAGGTCCCAAGGGTTGGGCTGTTCGCCCATTAAAGCGGCACGCGAGCTGGGTTTAGAACGTCGTGAGACAGTTCGGTCTCTATCCGCCGCGCGCGTCAGAAGCTTGAGGAAAGCTGTCCCTAGTACGAGAGGACCGGGACGGACGAACCTCTGGTCCACCAGTTGTCCCACCAGGGGCACCGCTGGATAGCCACGTTCGGACAGGATAACCGCTGAAAGCATCTAAGCGGGAAACCTTCTCCAAGACCAGGCTTCTCACCCATTAAGTGGGATAAGGCCCCCCGCAGACCACGGGATCGATAGACCAGACCTGTAACCGCAGCAATG			-30.88	gnl|BL_ORD_ID|367813|hsp_num:0	2811	True	loose hit with at least 95 percent identity pushed strict
2811_4157 | model_type_id: 40295 | pass_bit_score: 5700 | SNP: A2272C,A2274G,A2274U | Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin | QUERY: k141_812013	k141_388674	964	3	-	Strict	5700	1531.99	Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin	95.43	3004164	rRNA gene variant model	A2274G	n/a	macrolide antibiotic	antibiotic target alteration	23S rRNA with mutation conferring resistance to macrolide antibiotics	TAAACGGCGGTGGTAACTATAACCATCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCTGCACGAATGGCGTAACGACTTCTCAACTGTCTCAACCATAGACTCGGCGAAATTGCACTACGAGTAAAGATGCTCGTTACGCGCGGCAGGACGAAAAGACCCCGGGACCTTCACTATAGCTTGGTATTGATGTTCGATACGGTTTGTGTAGGATAGGTGGGAGACTATGAAGCGATA-ACGCCAGTTATTGTGGAGTCGTTGTTGAAATACCACTCTGATCGTATTGGACCTCTAACTTCGAACCGTATATCCGGTTCAGGGACAGTGCCTGGTGGGTAGTTTAACTGGGGCGGTTGCCTCCTAAAAAGTAACGGAGGCGCCCAAAGGTTCCCTCAACCTGGACGGCAATCAGGTGTTGAGTGCAAGTGCACAAGGGAGCTTGACTGCGAGACATACATGTCGAGCAGGGACGAAAGTCGGGACTAGTGATCCGGCACCTCTGAGTGGAAGGGGTGTCGCTCAACGGATAAAAGGTACCCCGGGGATAACAGGCTGATCTTCCCCAAGAGTCCATATCGACGGGATGGTTTGGCACCTCGATGTCGGCTCGTCGCATCCTGGGGCTGGAGCAGGTCCCAAGGGTTGGGCTGTTCGCCCATTAAAGCGGCACGCGAGCTGGGTTTAGAACGTCGTGAGACAGTTCGGTCTCTATCCGCCGCGCGCGTCAGAAGCTTGAGGAAAGCTGTCCCTAGTACGAGAGGACCGGGACGGACGAACCTCTGGTCCACCAGTTGTCCCACCAGGGGCACCGCTGGATAGCCACGTTCGGACAGGATAACCGCTGAAAGCATCTAAGCGGGAAACCTTCTCCAAGACCAGGCTTCTCACCCATTAAGTGGGATAAGGCCCCCCGCAGACCACGGGATCGATAGACCAGACCTGTAACCGCAGCAATG			-30.88	gnl|BL_ORD_ID|367813|hsp_num:0	2811	True	loose hit with at least 95 percent identity pushed strict
2811_4157 | model_type_id: 40295 | pass_bit_score: 5700 | SNP: A2272C,A2274G,A2274U | Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin | QUERY: k141_32499	k141_388674	964	3	-	Strict	5700	1531.99	Mycobacterium avium 23S rRNA with mutation conferring resistance to clarithromycin	95.43	3004164	rRNA gene variant model	A2274G	n/a	macrolide antibiotic	antibiotic target alteration	23S rRNA with mutation conferring resistance to macrolide antibiotics	TAAACGGCGGTGGTAACTATAACCATCCTAAGGTAGCGAAATTCCTTGTCGGGTAAGTTCCGACCTGCACGAATGGCGTAACGACTTCTCAACTGTCTCAACCATAGACTCGGCGAAATTGCACTACGAGTAAAGATGCTCGTTACGCGCGGCAGGACGAAAAGACCCCGGGACCTTCACTATAGCTTGGTATTGATGTTCGATACGGTTTGTGTAGGATAGGTGGGAGACTATGAAGCGATA-ACGCCAGTTATTGTGGAGTCGTTGTTGAAATACCACTCTGATCGTATTGGACCTCTAACTTCGAACCGTATATCCGGTTCAGGGACAGTGCCTGGTGGGTAGTTTAACTGGGGCGGTTGCCTCCTAAAAAGTAACGGAGGCGCCCAAAGGTTCCCTCAACCTGGACGGCAATCAGGTGTTGAGTGCAAGTGCACAAGGGAGCTTGACTGCGAGACATACATGTCGAGCAGGGACGAAAGTCGGGACTAGTGATCCGGCACCTCTGAGTGGAAGGGGTGTCGCTCAACGGATAAAAGGTACCCCGGGGATAACAGGCTGATCTTCCCCAAGAGTCCATATCGACGGGATGGTTTGGCACCTCGATGTCGGCTCGTCGCATCCTGGGGCTGGAGCAGGTCCCAAGGGTTGGGCTGTTCGCCCATTAAAGCGGCACGCGAGCTGGGTTTAGAACGTCGTGAGACAGTTCGGTCTCTATCCGCCGCGCGCGTCAGAAGCTTGAGGAAAGCTGTCCCTAGTACGAGAGGACCGGGACGGACGAACCTCTGGTCCACCAGTTGTCCCACCAGGGGCACCGCTGGATAGCCACGTTCGGACAGGATAACCGCTGAAAGCATCTAAGCGGGAAACCTTCTCCAAGACCAGGCTTCTCACCCATTAAGTGGGATAAGGCCCCCCGCAGACCACGGGATCGATAGACCAGACCTGTAACCGCAGCAATG			-30.88	gnl|BL_ORD_ID|367813|hsp_num:0	2811	True	loose hit with at least 95 percent identity pushed strict
